<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27457812</article-id>
<article-id pub-id-type="pmc">5658665</article-id>
<article-id pub-id-type="pii">mp2016109</article-id>
<article-id pub-id-type="doi">10.1038/mp.2016.109</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Exome sequencing of Pakistani consanguineous families identifies 30 novel
candidate genes for recessive intellectual disability</article-title>
<alt-title alt-title-type="running">Genetics of autosomal recessive intellectual disability</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Riazuddin</surname>
<given-names>S</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="author-notes" rid="note3">
<sup>16</sup>
</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hussain</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="author-notes" rid="note3">
<sup>16</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Razzaq</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="author-notes" rid="note3">
<sup>16</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iqbal</surname>
<given-names>Z</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="author-notes" rid="note1">
<sup>14</sup>
</xref>
<xref ref-type="author-notes" rid="note3">
<sup>16</sup>
</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6387-8019</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shahzad</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Polla</surname>
<given-names>D L</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Y</given-names>
</name>
<xref ref-type="aff" rid="aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Beusekom</surname>
<given-names>E</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khan</surname>
<given-names>A A</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tomas-Roca</surname>
<given-names>L</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rashid</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zahoor</surname>
<given-names>M Y</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wissink-Lindhout</surname>
<given-names>W M</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Basra</surname>
<given-names>M A R</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ansar</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff5">5</xref>
<xref ref-type="author-notes" rid="note2">
<sup>15</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Agha</surname>
<given-names>Z</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Heeswijk</surname>
<given-names>K</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rasheed</surname>
<given-names>F</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van de Vorst</surname>
<given-names>M</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Veltman</surname>
<given-names>J A</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1693-9699</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akram</surname>
<given-names>J</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Assir</surname>
<given-names>M Z</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<collab>UK10K</collab>
<xref ref-type="aff" rid="aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grozeva</surname>
<given-names>D</given-names>
</name>
<xref ref-type="aff" rid="aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carss</surname>
<given-names>K</given-names>
</name>
<xref ref-type="aff" rid="aff12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Raymond</surname>
<given-names>F L</given-names>
</name>
<xref ref-type="aff" rid="aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O'Connor</surname>
<given-names>T D</given-names>
</name>
<xref ref-type="aff" rid="aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Riazuddin</surname>
<given-names>S A</given-names>
</name>
<xref ref-type="aff" rid="aff13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khan</surname>
<given-names>S N</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ahmed</surname>
<given-names>Z M</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Brouwer</surname>
<given-names>A P M</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Bokhoven</surname>
<given-names>H</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="author-notes" rid="note4">
<sup>17</sup>
</xref>
<xref ref-type="corresp" rid="caf2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Riazuddin</surname>
<given-names>S</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="author-notes" rid="note4">
<sup>17</sup>
</xref>
<xref ref-type="corresp" rid="caf3">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Department of
Otorhinolaryngology—Head and Neck Surgery, University of Maryland,
School of Medicine</institution>, Baltimore, MD,
<country>USA</country></aff>
<aff id="aff2"><label>2</label><institution>Center for Genetic Diseases, Shaheed
Zulfiqar Ali Bhutto Medical University, Pakistan Institute of Medical
Sciences</institution>, Islamabad, <country>Pakistan</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Human Genetics, Donders
Institute for Brain, Cognition and Behaviour, Radboud University Medical
Center</institution>, Nijmegen, <country>The Netherlands</country></aff>
<aff id="aff4"><label>4</label><institution>Allama Iqbal Medical College,
University of Health Sciences</institution>, Lahore,
<country>Pakistan</country></aff>
<aff id="aff5"><label>5</label><institution>National Centre of Excellence in
Molecular Biology, University of The Punjab</institution>, Lahore,
<country>Pakistan</country></aff>
<aff id="aff6"><label>6</label><institution>Center for Genetic Diseases, CAPES
Foundation, Ministry of Education of Brazil</institution>,
Brasília, <country>Brazil</country></aff>
<aff id="aff7"><label>7</label><institution>Institute for Genome Sciences and
Program in Personalized and Genomic Medicine, University of Maryland, School
of Medicine</institution>, Baltimore, MD,
<country>USA</country></aff>
<aff id="aff8"><label>8</label><institution>Department of Biosciences, Faculty of
Science, COMSATS Institute of Information Technology</institution>,
Islamabad, <country>Pakistan</country></aff>
<aff id="aff9"><label>9</label><institution>Department of Clinical Genetics, GROW
School for Oncology and Developmental Biology, Maastricht University Medical
Centre</institution>, Maastricht, <country>The Netherlands</country></aff>
<aff id="aff10"><label>10</label><institution>The Wellcome Trust Sanger
Institute, Wellcome Trust Genome Campus</institution>, Cambridge,
<country>UK</country></aff>
<aff id="aff11"><label>11</label><institution>Department of Medical Genetics,
Cambridge Institute for Medical Research, University of Cambridge</institution>,
Cambridge, <country>UK</country></aff>
<aff id="aff12"><label>12</label><institution>Department of Haematology,
University of Cambridge</institution>, Cambridge, <country>UK</country></aff>
<aff id="aff13"><label>13</label><institution>Department of Ophthalmology, The
Wilmer Eye Institute, Johns Hopkins University School of Medicine</institution>,
Baltimore, MD, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Department of Otorhinolaryngology—Head and Neck
Surgery, University of Maryland School of Medicine</institution>,
Baltimore, MD
21201, <country>USA</country>E-mail: <email>sriazuddin@smail.umaryland.edu</email></corresp>
<corresp id="caf2"><label>*</label><institution>Department of Human Genetics, Donders Institute for
Brain, Cognition and Behaviour, Radboud University Medical Center</institution>,
PO BOX 9101, Nijmegen
6500 HB, <country>The Netherlands</country>E-mail: <email>Hans.vanbokhoven@radboudumc.nl</email></corresp>
<corresp id="caf3"><label>*</label><institution>Allama Iqbal Medical College, University of Health
Sciences</institution>, Lahore
54550, <country>Pakistan</country>. E-mail: <email>riazuddin@aimrc.org</email></corresp>
<fn fn-type="present-address" id="note1">
<label>14</label>
<p>Current address: Department of Neurology, Oslo University Hospital, Oslo,
Norway.</p>
</fn>
<fn fn-type="present-address" id="note2">
<label>15</label>
<p>Current address: Department of Genetic Medicine and Development, University
of Geneva, Geneva, Switzerland.</p>
</fn>
<fn fn-type="equal" id="note3">
<label>16</label>
<p>These authors share equal first authorship.</p>
</fn>
<fn fn-type="equal" id="note4">
<label>17</label>
<p>These authors share equal senior authorship.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>22</volume>
<issue>11</issue>
<fpage>1604</fpage>
<lpage>1614</lpage>
<history>
<date date-type="received">
<day>16</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>18</day>
<month>05</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>06</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 The Author(s)</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>The Author(s)</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--author-paid-->
<license-p>This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this article
are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative
Commons license, users will need to obtain permission from the license holder to
reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p>
</license>
</permissions>
<abstract>
<p>Intellectual disability (ID) is a clinically and genetically heterogeneous
disorder, affecting 1–3% of the general population. Although
research into the genetic causes of ID has recently gained momentum,
identification of pathogenic mutations that cause autosomal recessive ID (ARID)
has lagged behind, predominantly due to non-availability of sizeable families.
Here we present the results of exome sequencing in 121 large consanguineous
Pakistani ID families. In 60 families, we identified homozygous or compound
heterozygous DNA variants in a single gene, 30 affecting reported ID genes and
30 affecting novel candidate ID genes. Potential pathogenicity of these alleles
was supported by co-segregation with the phenotype, low frequency in control
populations and the application of stringent bioinformatics analyses. In another
eight families segregation of multiple pathogenic variants was observed,
affecting 19 genes that were either known or are novel candidates for ID.
Transcriptome profiles of normal human brain tissues showed that the novel
candidate ID genes formed a network significantly enriched for transcriptional
co-expression (<italic>P&lt;</italic>0.0001) in the frontal cortex during fetal
development and in the temporal–parietal and sub-cortex during infancy
through adulthood. In addition, proteins encoded by 12 novel ID genes directly
interact with previously reported ID proteins in six known pathways essential
for cognitive function (<italic>P&lt;</italic>0.0001). These results suggest that
disruptions of temporal parietal and sub-cortical neurogenesis during infancy
are critical to the pathophysiology of ID. These findings further expand the
existing repertoire of genes involved in ARID, and provide new insights into the
molecular mechanisms and the transcriptome map of ID.</p>
</abstract>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Intellectual disability (ID) is a common neurodevelopmental disorder with an
onset of cognitive impairment before the age of 18 years<sup><xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib2">2</xref>, <xref ref-type="bibr" rid="bib3">3</xref></sup> and is characterized by significant limitations in
intellectual functioning and adaptive behavior.<sup><xref ref-type="bibr" rid="bib1">1</xref></sup> The disease affects 1–3% of the world
population; however, its prevalence in the developing world is almost twice that
of the affluent world.<sup><xref ref-type="bibr" rid="bib4">4</xref>, <xref ref-type="bibr" rid="bib5">5</xref></sup> The causes of nearly 40% of ID remain
ambiguous.<sup><xref ref-type="bibr" rid="bib6">6</xref></sup> Among the known
causes, ~50% of ID cases have an environmental etiology such as poor
nutrition, multiple pregnancies with little gap, prenatal/perinatal brain
ischemia, postnatal infections and inadequate medical services. The other half
of ID cases has a genetic etiology, such as chromosomal abnormalities or
mutations in specific genes.<sup><xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib5">5</xref></sup></p>
<p>In the western world, <italic>de novo</italic> heterozygous mutations and genomic copy
number changes account for the majority of ID cases.<sup><xref ref-type="bibr" rid="bib7">7</xref></sup> In contrast, recessive ID appears to be more common
in consanguineous populations. Identification of gene mutations that cause
non-syndromic autosomal recessive ID (ARID) has been notoriously slow because of
the scarcity of sizeable families. By 2006, only three genes, <italic>CC2D1A</italic>,
<italic>CRBN</italic> and <italic>PRSS12</italic> had been associated with
ARID.<sup><xref ref-type="bibr" rid="bib8">8</xref>, <xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib10">10</xref></sup> After 2006,
research studies involving highly inbred populations from North Africa, the
Middle East and South East Asia, greatly accelerated the pace of identification
of gene mutations that cause ARID. These studies were further augmented by the
use of next-generation sequencing. In 2011, Najmabadi <italic>et
al.</italic><sup><xref ref-type="bibr" rid="bib11">11</xref></sup> applied targeted
next-generation sequencing to 136 consanguineous Iranian families, in which
homozygosity mapping had previously identified a locus, and reported 23 known
and 50 new candidate ARID genes. More recently, exome sequencing (ES) of 143
large consanguineous Saudi Arabian families revealed 33 novel candidate genes
involved in different neurological disorders.<sup><xref ref-type="bibr" rid="bib12">12</xref></sup> These studies further highlighted the clinical and
genetic complexity of ID and other neurodevelopmental disorders. Intriguingly,
not a single gene with pathogenic variants emerged across various populations.
Despite this progress, a large number of potential pathogenic gene mutations
remain unidentified and warrant further studies in extended families from
communities with endogamy.</p>
<p>Consanguineous marriages are practiced by about 20% of the human
population, and the extent of consanguinity varies among different citizenry in
the world. The rate of consanguineous marriages is 38% in
Iran,<sup><xref ref-type="bibr" rid="bib13">13</xref>, <xref ref-type="bibr" rid="bib14">14</xref></sup> over 40% in several Middle Eastern
countries<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> and above
50% in Pakistan.<sup><xref ref-type="bibr" rid="bib16">16</xref></sup> The elevated
level of endogamy in Pakistan has led to the increased prevalence of genetic
disorders, including ARID, with an average of 1.1 cases of severe ID and 6.2
cases of mild ID per 100 live births.<sup><xref ref-type="bibr" rid="bib17">17</xref></sup> The present study is designed to identify pathogenic
gene mutations that cause ARID in the highly inbred population of Pakistan. In
all, 121 families of 8 different ethnicities, exhibiting recessive ID, were
enrolled mostly from the rural population of Pakistan. Through a systematic
exome-sequencing approach we have identified potential pathogenic variants in 68
of these families: 30 families with a single homozygous DNA variant affecting
previously known ID genes and another 30 families with a single homozygous or
compound heterozygous variants in novel candidate ID genes. In eight families
multiple homozygous variants were identified. We report the
phenotype–genotype relationships, the predicted pathogenicity of the newly
discovered candidate genes, their co-expression in functional networks in the
developing and adult human brain, and possible involvement in various cellular
processes.</p>
</sec>
<sec>
<title>Materials and methods</title>
<sec>
<title>Family ascertainment and phenotype analysis</title>
<p>This study was approved by the Institutional Review Board of the Centre of
Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore,
Pakistan and the Medical Ethical Committee Arnhem-Nijmegen, The Netherlands.
The families of our cohort were obtained mainly from the rural populations
of all five provinces of Pakistan (<xref ref-type="supplementary-material" rid="sup1">Supplementary Tables
S1 and S2</xref>). Written informed consents were obtained from
healthy adult subjects and the parents/legal guardians of minor subjects
and ID patients. Specific informed consent was obtained for showing images
of patients (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S1</xref>).
Participating individuals were evaluated with medical history interviews,
and ID-related phenotypic features of patients were recorded. All affected
individuals were clinically evaluated by both a geneticist and a general
medical practitioner, with particular attention to neurological,
morphological, ophthalmological, dermatological and skeletal symptoms.
Photographs of the face and uncovered limbs were also taken (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S1</xref>). In some cases, magnetic
resonance imaging and computerized tomography scans were also obtained. A
description of developmental milestones was used to evaluate the severity of
ID.<sup><xref ref-type="bibr" rid="bib18">18</xref></sup> Only families with
confirmed existence of cognitive dysfunction in the affected members were
included in this study. Peripheral blood samples were collected from
participating subjects. Genomic DNA was isolated following standard
procedures.<sup><xref ref-type="bibr" rid="bib19">19</xref></sup></p>
</sec>
<sec>
<title>Exome sequencing and variant selection</title>
<p>Exome enrichment and high-throughput sequencing were performed at the
Radboudumc (Nijmegen, The Netherlands), The Wellcome Trust Sanger Institute
(Hinxton, as part of the UK10K study) and the University of Maryland as
previously described.<sup><xref ref-type="bibr" rid="bib20">20</xref></sup> Selection
of high-quality, potentially pathogenic variants was performed using seven
major filtration steps (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure
S2</xref> and <xref ref-type="supplementary-material" rid="sup1">Supplementary
Methods</xref>).</p>
</sec>
<sec>
<title>Sanger sequencing</title>
<p>ES results were confirmed by Sanger sequencing. Primers for the amplification
of the exons carrying variants were designed by using Primer3 (ref. <xref ref-type="bibr" rid="bib21">21</xref>; <xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S9
and S10</xref>).</p>
</sec>
<sec>
<title>Predicted involvement of candidate genes in cellular processes and
pathways</title>
<p>We researched the available literature and extracted all reported
protein–protein interactions involving the known and the newly
identified ID proteins and then entered them into a set of
protein–protein interaction networks via the STRING<sup><xref ref-type="bibr" rid="bib22">22</xref></sup> and MATISSE<sup><xref ref-type="bibr" rid="bib23">23</xref></sup> algorithms, which are included in the EXPANDER
package tools.<sup><xref ref-type="bibr" rid="bib24">24</xref></sup></p>
</sec>
<sec>
<title>Expression of candidate genes in the human brain</title>
<p>Brain expression analyses for new ARID genes were conducted using existing
data sets in the BrainSpan: Atlas of the Developing Human
Brain.<sup><xref ref-type="bibr" rid="bib25">25</xref></sup> Normalized gene
expression levels for 26 different brain tissues from 31 different
developmental periods were obtained from the BrainSpan RNA-seq data set v3
(<ext-link ext-link-type="uri" xlink:href="http://brainspan.org" xmlns:xlink="http://www.w3.org/1999/xlink">http://brainspan.org</ext-link>) of the developing human brain.</p>
</sec>
<sec>
<title>Co-expression network analysis</title>
<p>Networks of functionally co-expressed genes were identified by using the
model of Gulsuner <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib26">26</xref></sup> Using the BrainSpan database, gene pairs are defined
as connected if the absolute value of the Pearson’s correlation
coefficient is &gt;0.8 for their expression levels in different brain
regions (frontal cortex, temporal-parietal, sensory–motor and
sub-cortical) and different developmental stages (fetal, infancy to late
childhood and adolescence to adulthood), totaling 12 different networks. For
each of these networks the numbers of edges (connections) between each of
the novel ID genes was calculated. Random simulations of 10 000
replicates of an equal number of genes randomly selected from the BrainScan
database were conducted to establish the significance of the connections.
This provided a distribution of edges to estimate an empirical
<italic>P</italic>-value for our novel ID genes.</p>
<p>In addition, we also randomly selected genes from the BrainScan database with
an HGNC gene symbol, as well as at least one connection in the temporal
region network. We compared an equal number of genes in this set with our ID
genes that passed the same filtering criterion, which provided more
conservative and consistent <italic>P</italic>-values.</p>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title>Recruitment of families</title>
<p>We enrolled a cohort of 121 ID families with a likely autosomal recessive
inheritance pattern mostly from the rural areas of Punjab, Sindh,
Baluchistan, Khyber Pakhtoon Khawa and Northern areas. The enrolled families
comprise eight ethnic groups, namely Punjabi (68.6%), Siraiki
(10.8%), Pathan (9%), Urdu speaking (7.8%) and others
(Sindhi, Afghan, Baloch and Kashmiri (3.8%); <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1</xref>). Every family had two or more
affected individuals (except PKMR51a) and 111 families had consanguineous
unions, while in 74 families the affected individuals were present in
separate sibships (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table
S2</xref>).</p>
</sec>
<sec>
<title>Genetic analysis</title>
<p>Before ES, the presence of disease-causing copy number variations was
excluded by SNP microarray analysis (Affymetrix 250 K SNP array or
higher coverage). ES was carried out for DNA samples of 1–3
individuals per family. Selection of the nucleotide variants was performed
using the seven-tier filtering strategy (<xref ref-type="supplementary-material" rid="sup1">Supplementary
Figure S2</xref>). Sanger sequencing confirmed 359 candidate
pathogenic variants. Of these, 80 variants in 77 genes segregated with the
ID phenotype. There are six categories of evidence that we are using in this
study to support an assertion that a variant is potentially pathogenic.
These are (1) segregation analysis; (2) either absence in the dbSNP142
database or a very low allele frequency (&lt;0.01) in the ExAC Browser
database; (3) absence in 213 ethnically matched control individuals; (4) a
CADD score &gt;20; (5) pathogenicity prediction by multiple <italic>in
silico</italic> programs; and (6) enrichment of loss-of-function (LOF) and
potentially pathogenic variants of known and novel ID genes in patients with
ID as compared with individuals with the non-ID phenotype
(<italic>n</italic>=213; <xref ref-type="supplementary-material" rid="sup1">Supplementary Table
S3</xref>).</p>
</sec>
<sec>
<title>Pathogenic variants identified in previously reported ARID
genes</title>
<p>We identified 34 predicted pathogenic variants in 32 genes previously
associated with ID or related neurodevelopmental disorders (<xref ref-type="table" rid="tbl1">Tables 1</xref> and 3a; <xref ref-type="supplementary-material" rid="sup1">Supplementary
Figures S3 and S6</xref>). These variants include homozygous
missense (<italic>n</italic>=21), nonsense (<italic>n</italic>=5), frameshift
(<italic>n</italic>=5) and splice site variants (<italic>n</italic>=3).
Twenty-five of these variants are novel (<xref ref-type="table" rid="tbl1">Tables
1</xref> and 3a). All new variants segregated with the disease and
were either absent in dbSNP142 or had an allele frequency ⩽0.002 in the
ExAC Browser<sup><xref ref-type="bibr" rid="bib27">27</xref></sup> (<xref ref-type="table" rid="tbl1">Tables 1</xref> and 3a).</p>
<p>Most genes were found to be mutated in only one family, suggesting a low
incidence of founder mutations underlying ID in the Pakistani population.
Two genes, <italic>TMEM67</italic> and <italic>FRAS1</italic>, which carried different
variants in two independent families (<xref ref-type="table" rid="tbl1">Tables 1</xref>
and 3a). Two families (PKMR61b and PKMR69) carry one homozygous variant each
in two unrelated but known ID genes. PKMR61b has variants in <italic>TMEM67</italic>
and <italic>FGFR1</italic> while PKMR69 has variants in <italic>FRAS1</italic> and
<italic>EXOSC8</italic> (Table 3a; <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure
S6</xref>). No carriers of these variants, which were both predicted
to be damaging and disease causing, were detected in our population-specific
controls. Two families each harbored a variant in an X-linked gene
(<italic>ZNF41</italic> and <italic>FLNA</italic>).</p>
<p>A comparison of the phenotypes of 34 variants in genes known to cause ID
shows that in most families the phenotype is similar to the reported entity
(<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S4</xref>). Some
deviations do occur, which may result from variable effects of allelic
mutations or the effects of genetic modifier variants, which may be
particularly relevant in populations with a high consanguinity
rate.<sup><xref ref-type="bibr" rid="bib28">28</xref>, <xref ref-type="bibr" rid="bib29">29</xref></sup></p>
</sec>
<sec>
<title>Pathogenic variants identified in novel candidate ARID genes</title>
<p>In 30 families we identified plausible pathogenic variants affecting a single
gene that had not been previously implicated in ARID (<xref ref-type="table" rid="tbl2">Table 2</xref>; <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure
S4</xref>). The majority of these changes were missense variants
(<italic>n</italic>=23). In addition, we identified frameshift
(<italic>n</italic>=6), nonsense (<italic>n</italic>=1) and splice site
(<italic>n</italic>=1) variants that result in a truncated protein or are
predicted to result in nonsense-mediated RNA decay. None of the variants
were found in 213 unrelated, ethnically matched control individuals,
indicating that they are not indigenous Pakistani polymorphisms. Clustal W
(<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/msa/clustalw2/" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.ebi.ac.uk/Tools/msa/clustalw2/</ext-link>) alignment of
protein sequences encompassing the missense variants showed that most of the
mutated amino acids are evolutionarily conserved (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S5</xref>). In 9 of the families there were no
notable clinical characteristics besides ID, whereas 21 families exhibited
syndromic forms of ID (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table
S5</xref>).</p>
<p>In family PKMR159 a compound heterozygous change was detected in
<italic>AACS</italic> and both variants have a frequency &lt;0.0002 in the ExAC
database<sup><xref ref-type="bibr" rid="bib27">27</xref></sup> (<xref ref-type="table" rid="tbl2">Table 2</xref>). <italic>In silico</italic> programs support a
pathogenic nature of these variants, suggesting that both alleles are
pathogenic and may contribute to the ID phenotype. In family PKMR72 a
synonymous change (c.2232A&gt;G, p.(Arg813Arg)) was identified in
<italic>MDGA2</italic> in the acceptor splice site of exon 13, which is
predicted to affect splicing by three splice prediction programs
(NNSPLICE<sup><xref ref-type="bibr" rid="bib30">30</xref></sup>,
HSF<sup><xref ref-type="bibr" rid="bib31">31</xref></sup> and
MaxEntScan<sup><xref ref-type="bibr" rid="bib32">32</xref></sup>).</p>
<p>In eight families, variants in more than one gene were identified (<xref ref-type="table" rid="tbl3a">Tables 3a</xref> and <xref ref-type="table" rid="tbl3b">3b</xref>,;
<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S6</xref>). Four of these
genes have already been implicated in a neurological disease
(<italic>TMEM67</italic>, <italic>FGFR1</italic>, <italic>FRAS1</italic> and <italic>EXOSC8</italic>),
but most variants affect genes that have not previously been connected to
human disease phenotypes. Of the 19 co-segregating variants, 18 are missense
variants and 1 is a splice site mutation. The identification of multiple
variants co-segregating with the disorder suggests the possible existence of
composite phenotypes (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table
S6</xref>), which might be a relatively common phenomenon in
consanguineous populations.</p>
<p>Next, to determine the functional effect of variants, especially missense, on
the secondary structure, stability and interactions of novel candidate ID
proteins, we performed <italic>in silico</italic> molecular modeling using the HOPE
and Pyre2 web-based programs. On the basis of the amino-acid sequence and
structural homology with proteins with resolved crystal structures, we
evaluated the effect of novel missense alleles in new ID proteins (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S7</xref>). The identified variants
are predicted to alter the function of the encoded proteins through their
effect (loss off ionic interactions, loss of external interactions,
de-stabilization of the core or the provision of more rigidity) on the
secondary structure (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure
S7</xref>).</p>
</sec>
<sec>
<title>Newly identified ARID proteins participate in essential regulatory
networks</title>
<p>Next, we applied Ingenuity Pathway Analysis<sup><xref ref-type="bibr" rid="bib33">33</xref></sup> to visualize the interactions between the 485
previously reported ID proteins (<ext-link ext-link-type="uri" xlink:href="http://gfuncpathdb.ucdenver.edu/iddrc/iddrc/GeneQuest.php" xmlns:xlink="http://www.w3.org/1999/xlink">http://gfuncpathdb.ucdenver.edu/iddrc/iddrc/GeneQuest.php</ext-link>)
and our novel candidate ID genes to identify the biological pathways
underlying the disease process. The overall analysis, which includes
physical interactions, co-expression, activation, inhibition and
protein–RNA interactions, suggests that most novel ARID candidate
proteins are part of already-established molecular ID gene networks (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). By taking only physical interactions
into account, we found the integration of several new ARID candidate
proteins in oxidative phosphorylation, mitochondrial dysfunction, PTEN
signaling and PPAR/RXR activation (<italic>P&lt;</italic>0.0001; <xref ref-type="fig" rid="fig1">Figure 1a</xref>).</p>
</sec>
<sec>
<title>Functional co-expression networks of ARID genes</title>
<p>To gain insight into the spatio-temporal expression pattern of the new
candidate ARID genes, we extracted the mRNAseq data from the Allen Brain
Atlas<sup><xref ref-type="bibr" rid="bib34">34</xref></sup> and analyzed the
expression patterns in developing and adult human brain tissues (<xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S7 and S8</xref>). All new candidate
ARID genes are expressed in the human brain from a very early development
stage to adulthood (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table
S8</xref>).</p>
<p>When examining the co-expression functional networks for our genes from the
BrainScan database, we find that they are significantly
(Bonferroni-corrected <italic>α</italic>⩽0.0042) co-expressed in the adult
brain in all four brain regions and that they are significantly
(Bonferroni-corrected <italic>P</italic>-value &lt;0.0001) co-expressed in the
temporal–parietal and sub-cortical regions from infancy to late
childhood (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). The phenotype observed in
most of our ID families is established at birth, so to further evaluate
co-expression during embryonic stages, we re-examined the normalized mRNAseq
data at various post-conception weeks (p.c.w.). We found significant
co-expression of ID genes in the frontal cortex region from 12 p.c.w.
onwards (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). Later in embryonic
development (24–37 p.c.w.) ID genes are also co-expressed in the
temporal–parietal and sub-cortical regions (<xref ref-type="fig" rid="fig2">Figure
2b</xref>), which persisted from infancy to late childhood (<xref ref-type="fig" rid="fig2">Figure 2a</xref>).</p>
</sec>
</sec>
<sec>
<title>Discussion</title>
<p>We report the results of ES in a cohort of 121 consanguineous Pakistani families.
Likely causative variants in known ID genes were identified in 30 of these
families. In addition, a single likely pathogenic variant affecting genes not
previously implicated in ID was identified in 30 families, and 8 families had
multiple variants segregating with the ID phenotype (<xref ref-type="fig" rid="fig3">Figure
3</xref>). Replication of this study in independent families is warranted
to add these genes to the rapidly growing list of bona fide genes implicated in
ID. In fact, during the submission phase of this manuscript-independent
mutations in ARID phenotypes were already reported for two genes: <italic>DPH1</italic>
(ref. <xref ref-type="bibr" rid="bib35">35</xref>) and <italic>TANGO2</italic>.<sup><xref ref-type="bibr" rid="bib36">36</xref>, <xref ref-type="bibr" rid="bib37">37</xref></sup> Other
arguments that strengthen the involvement of the candidate ID genes are the
disruptive nature of missense mutations as observed by modeling of the protein
structure (<xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S7</xref>), the
co-occurrence of ARID candidate genes in common regulatory pathways (<xref ref-type="fig" rid="fig1">Figure 1</xref>) and the co-expression of these genes in
distinct regions of the human brain (<xref ref-type="fig" rid="fig2">Figure 2</xref>).
Further credit for the involvement of the new candidate ID genes is provided by
the pattern of mutations. The frequency of predicted LOF alleles (that is,
nonsense, frameshift or splice site variants) in known ID genes is 13/34
(38.24%), whereas their occurrence for new candidate genes is 8/30
(26.67%), and only 1/15 (6.67%) for candidate genes in
families with multiple segregating variants. These LOF variants in the new
candidate genes, <italic>METTL4</italic>, <italic>METTL5</italic>, <italic>CAPN12</italic>,
<italic>MDGA2</italic>, <italic>UBE2J2</italic>, <italic>CCDC82</italic>, <italic>PUS7</italic>,
<italic>SLC7A10</italic> and <italic>TBC1D23</italic>, have the highest confidence of
causality. In addition, we analyzed the exomes of 213 unrelated Pakistani
control individuals for variants affecting the known ID genes and the novel
candidate ID genes that we have identified in our cohort. Importantly,
homozygous and compound heterozygous variants that would have passed our
stringent filtering criteria were identified in eight different genes. Five of
these are known ID genes (<italic>APTX</italic>, <italic>ASPM</italic>, <italic>FLNA</italic>,
<italic>POMT2</italic> and <italic>SYNE1</italic>), and only three are new candidate ID
genes, of which two were found in families with multiple segregating variants
(<italic>ESYT3</italic> and <italic>SLC45A4</italic>) and one affecting a gene
(<italic>GGN</italic>) that harbored the single segregating variant in the respective
family. The relative high occurrence of LOF alleles in families with single
segregating variants, as well as the paucity of predicted pathogenic variants in
these genes in a control cohort provides strong support for the involvement of
the candidate ID genes listed in <xref ref-type="table" rid="tbl2">Table 2</xref>.</p>
<p>Recently, ES of 3222 apparently healthy British adults of Pakistani heritage
revealed 1111 rare homozygous variants in 781 genes, including a frameshift
allele (c.658_659delAA) in one of the novel candidate genes
<italic>CAPN12</italic>.<sup><xref ref-type="bibr" rid="bib38">38</xref></sup> No other
homozygous LOF allele was observed in any novel ID candidate gene. We found the
same frameshift allele (<xref ref-type="table" rid="tbl2">Table 2</xref>) segregating with a
moderate ID phenotype (<xref ref-type="supplementary-material" rid="sup1">Supplementary Table S5</xref>)
in two affected individuals of family PKMR64 (<xref ref-type="supplementary-material" rid="sup1">Supplementary
Figure S4</xref>). There are at least three possible reasons to explain
these observations. First, the LOF variant we identified in <italic>CAPN12</italic> is
not causative for the moderate ID phenotype in family PKMR64, and
<italic>CAPN12</italic> should be discarded as candidate ID gene. Second, without
comprehensive assessment of mental health it is hard to rule out that the
British–Pakistani individual has a mild ID phenotype similar to the
phenotype in family PKMR64. Indeed, there are indications to question the health
status of all individuals of the British–Pakistani cohort. For example,
the reported genetic variants include homozygous LOF alleles in <italic>AHI1</italic>,
<italic>C12orf57</italic> and <italic>POMGNT1</italic> genes, which are known to underlie
the severe neurological disorders, Joubert syndrome<sup><xref ref-type="bibr" rid="bib39">39</xref></sup>, Temtamy syndrome<sup><xref ref-type="bibr" rid="bib40">40</xref></sup> and muscle–eye–brain disease and other
muscular dystrophy–dystroglycanopathies,<sup><xref ref-type="bibr" rid="bib41">41</xref></sup> respectively. Variants identified in the
British–Pakistani adults also include LOF alleles in <italic>GJB2</italic>,
<italic>MYO3A</italic> and <italic>COCH</italic> genes, which are known to cause hearing
loss in humans.<sup><xref ref-type="bibr" rid="bib42">42</xref>, <xref ref-type="bibr" rid="bib43">43</xref>, <xref ref-type="bibr" rid="bib44">44</xref></sup> Third, there
could be a protective or modifier genetic variant present in the British adult,
which could render the effect of c.658_659delAA allele of
<italic>CAPN12.</italic><sup><xref ref-type="bibr" rid="bib45">45</xref>, <xref ref-type="bibr" rid="bib46">46</xref></sup></p>
<p>In the remaining 53 families, no high-confidence DNA variants was identified.
This might be accounted for by several factors. First, it is possible that some
causative variants have not passed our stringent filtering criteria. Second,
genetic heterogeneity is likely to occur, even within some of the families we
have studied. Such phenocopies would disrupt the segregation of DNA variants
across all affected individuals in the studied pedigrees. Third, it is possible
that some of the phenotypes with mild to moderate ID are caused by the digenic
or oligogenic inheritance of rare variants or polymorphisms with low effect
size. Finally, some mutations may have escaped detection by ES and may reside in
non-coding regions or regions poorly covered by exonic enrichment.</p>
<sec>
<title>Intellectual disability and other neurodevelopmental
disorders</title>
<p>There is a growing body of evidence that categorical neurodevelopmental
disorders such as ID, autism spectrum disorders, attention
deficit/hyperactivity disorders and learning disorders lack precise
boundaries in their clinical definitions, epidemiology, genetics, and
molecular and cellular networks.<sup><xref ref-type="bibr" rid="bib47">47</xref>,
<xref ref-type="bibr" rid="bib48">48</xref>, <xref ref-type="bibr" rid="bib49">49</xref>, <xref ref-type="bibr" rid="bib50">50</xref>, <xref ref-type="bibr" rid="bib51">51</xref>, <xref ref-type="bibr" rid="bib52">52</xref></sup> Accordingly,
cognitive and behavioral comorbidities such as attention
deficit/hyperactivity disorders, speech delay and aggression are also
frequently seen in the ID families studied here. In our study, 21.88%
of the families (7 of 32) with mutations in known genes (<xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S4 and S6</xref>) and 33.33%
of the families (12 of 36) with variants in novel candidate ARID genes
resulting in clinical phenotypes that include epilepsy (<xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S5 and S6</xref>). These results are not
unexpected because the prevalence of epilepsy in individuals with some
degree of ID ranges from 5.5 to 35%.<sup><xref ref-type="bibr" rid="bib53">53</xref></sup> The prevalence of epilepsy grows with increasing
severity of ID, with 15% of individuals with mild to moderate ID also
exhibiting epilepsy and more than 30% of those with severe
ID.<sup><xref ref-type="bibr" rid="bib54">54</xref></sup> This high prevalence
underscores the importance of identifying largely unknown common genetic
factors with a causative role in epilepsy and ARID. A striking example is
provided by family PKMR82, in which a homozygous nonsense mutation
(p.Arg65*) in <italic>KCNA2</italic> was associated with mild to moderate ID,
speech delay, strabismus, walking delay and epilepsy. Recently, <italic>de novo
KCNA2</italic> missense mutations were associated with epileptic
encephalopathy, ataxia, variable ID<sup><xref ref-type="bibr" rid="bib55">55</xref>,
<xref ref-type="bibr" rid="bib56">56</xref></sup> and other features
reminiscent of those found in family PKMR82. These <italic>de novo</italic> missense
mutations exert dominant effects by gain-of-function and dominant-negative
mechanisms. The nonsense mutation in PKMR82 represents the first true LOF
allele of <italic>KCNA2</italic>, which apparently has no phenotypic consequences in
heterozygous mutation carriers.</p>
</sec>
<sec>
<title>Combinatorial ID phenotypes</title>
<p>We observed a syndromic ID phenotype in most of the studied families
(<xref ref-type="supplementary-material" rid="sup1">Supplementary Tables S4–S6</xref>).
These syndromic ID phenotypes could be attributed to the variant of a single
gene in most families, but we have also observed multiple independently
segregating variants in eight families (6.6%) of our cohort (<xref ref-type="table" rid="tbl3a">Tables 3a</xref> and <xref ref-type="table" rid="tbl3b">3b</xref>).
This high co-occurrence of multiple potential disease-causing alleles may
lead to the occurrence of composite recessive phenotypes. Both families
PKMR61b and PKMR69 have segregating variants in two independent known
disease genes. On the basis of the clinical presentation of previous
mutations, in families PKMR61b and PKMR69 it seems that the core phenotypic
features are attributable to just one of the two variants: <italic>TMEM67</italic>
in family PKMR61b and <italic>EXOSC8</italic> in family PKMR69. Such inferences
cannot be made for families in which segregating variants are seen in
multiple novel candidate ID genes. For example, in family PKMR131
independent variants in <italic>ESYT3</italic> and <italic>CCT6B</italic> are associated
with an unremarkable phenotype consisting of mild ID, speech delay, slow
learning and aggressive behavior. <italic>CCT6B</italic> and <italic>ESYT3</italic> have not
been connected to any human disorder so far, and therefore the variants in
either or both of these genes could contribute to the phenotype.</p>
</sec>
<sec>
<title>Functional properties of novel ARID genes</title>
<p>A comprehensive evaluation of the transcriptome profiles of normal human
brain tissues revealed that the ID genes are significantly co-expressed in
the frontal cortex region from 12 p.c.w. onwards, and in the
temporal–parietal and sub-cortical regions from infancy to late
childhood, implicating these regions in the pathogenesis of ID. These brain
regions incorporate external and internal information and their disruptions
have been associated with various disorders, such as amnesia,
Alzheimer’s disease and schizophrenia,<sup><xref ref-type="bibr" rid="bib57">57</xref></sup> which further support the notion of shared
molecular networks between various brain disorders. At later stages, we also
found significant co-expression in the frontal cortex and
sensory–motor regions (<xref ref-type="fig" rid="fig2">Figure 2a</xref>), which
suggests that many of the ID genes might also have an important role in
postnatal mechanisms, such as fine-tuning of synaptic connectivity,
circuitry formation, and acute synaptic and other neural processes. Evidence
for the involvement of postnatal mechanisms in ID is provided by studies
with conditional (postnatal) knockout mice,<sup><xref ref-type="bibr" rid="bib58">58</xref>, <xref ref-type="bibr" rid="bib59">59</xref></sup> as well as
studies with postnatal interventions in ID mouse models that are a basis of
clinical trials for human ID disorders, such as Fragile X syndrome, Down
syndrome and neurofibromatosis.<sup><xref ref-type="bibr" rid="bib60">60</xref>,
<xref ref-type="bibr" rid="bib61">61</xref>, <xref ref-type="bibr" rid="bib62">62</xref></sup></p>
</sec>
<sec>
<title>Common regulatory pathways involving new ARID genes</title>
<p>Only few of the novel ID genes seem to relate to molecular pathways and
networks that have been previously implicated in dominant and X-linked forms
of ID, such as pre- and post-synaptic signaling, transcription regulation
and epigenetic mechanisms.<sup><xref ref-type="bibr" rid="bib48">48</xref>, <xref ref-type="bibr" rid="bib51">51</xref>, <xref ref-type="bibr" rid="bib52">52</xref></sup> An
exception is <italic>UBE2J2</italic>, encoding a ubiquitin-conjugating enzyme, which
represents an emergent mechanism for regulating synapse function by
post-translational modification through the ubiquitin pathway at the
postsynaptic membrane.<sup><xref ref-type="bibr" rid="bib63">63</xref></sup>
Proteolysis by the ubiquitin proteosome pathway is recognized as a major
molecular pathway leading to several neurodevelopmental<sup><xref ref-type="bibr" rid="bib48">48</xref></sup> and neurodegenerative
diseases.<sup><xref ref-type="bibr" rid="bib64">64</xref></sup> Previously
identified gene networks that are commonly disrupted in ID and other
neurodevelopmental disorders are composed of genes that are highly
dosage-sensitive. Thus, these pathways might represent other neurobiological
processes than those that are affected by recessive mutations.</p>
</sec>
</sec>
<sec>
<title>Conclusion</title>
<p>Our study demonstrates the clinical utility of consanguineous populations for the
elucidation of the molecular basis of very heterogeneous recessive disorders.
Uncovering candidate genes for such disorders in inbred families will trigger
the identification of matching mutations in other populations. In addition, a
major strength of the present study is the presentation of the clinical profiles
in conjunction with the reported candidate gene mutations. Therefore, the large
collection of data presented in this manuscript is expected to facilitate the
interpretation of DNA variants in diagnostic exome studies of patients with
difficult-to-diagnose neurodevelopmental disorders. Future work using model
systems may aid in unraveling and revealing the functional integration of
different molecular networks in normal brain development and activity, which
could add another level to neurological disorder diagnosis and more effective
targeted therapy.</p>
</sec>
</body>
<back>
<ack>
<p>We thank the patients and their family for participating in our study. Many thanks to
R Yousaf and S Yousaf (University of Maryland, MD, USA), WM Nillesen, K Neveling and
Dr LE Vissers (Department of Human Genetics, Radboud University Medical Center,
Nijmegen, The Netherlands) for technical and bioinformatics assistance. This study
was supported by funds from the EU FP7 Large-Scale Integrating Project Genetic and
Epigenetic Networks in Cognitive Dysfunction (241995 to HvB and SR), Higher
Education Commission in Pakistan. Work in the US was supported by the funds from
University of Maryland. DLP is recipient of a CAPES Fellowship (13311/13-1).
This study made use of data generated by the UK10K Project. Funding for the UK10K
Project was provided by the Wellcome Trust under award WT091310. A full list of
consortium members can be found at the UK10K Project website (<ext-link ext-link-type="uri" xlink:href="http://www.uk10k.org" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.uk10k.org</ext-link>). We thank
the Exome Aggregation Consortium and the groups that provided exome variant data for
comparison. A full list of contributing groups can be found at <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/about" xmlns:xlink="http://www.w3.org/1999/xlink">http://exac.broadinstitute.org/about</ext-link>.</p>
<p>
<bold>Author contributions</bold>
</p>
<p>Conceived and designed the experiments: SR, ZMA, APMdB, HvB and ShR. Performed the
experiments: MH, AR, ZI, MS, DLP, YS, EvB, LT-R, MR, MYZ, WMW-L, MA, ZA, KvH, FR, CG
and APMdB. Analyzed the data: SR, MH, AR, ZI, MS, DLP, YS, AAK, KvH, WMW-L, MARB,
MvdV, CG, MZA, DG, KC, FLR, TDO’C, SAR, SNK, ZMA, APMdB, HvB and ShR.
Contributed reagents/materials/analysis tools: JAV, JA, TK, SAR, SNK, ZMA,
APMdB, HvB and ShR. Wrote the paper: SR, APMdB, HvB and ShR. All the authors read
the manuscripts and provided comments and have approved the final draft of the
manuscript.</p>
</ack>
<fn-group>
<fn>
<p><xref ref-type="supplementary-material" rid="sup1">Supplementary Information</xref> accompanies the paper on
the Molecular Psychiatry website (http://www.nature.com/mp)</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</fn-group>
<fn-group content-type="nature-chghst">
<fn fn-type="correctn">
<p content-type="chgdate">08/31/2018</p>
<p content-type="chgmade">This Article was originally published under a CC BY-NC-SA 4.0 license,
but has now been made available under a CC BY 4.0 license. The PDF and HTML
versions of the Article have been modified accordingly.</p>
</fn>
</fn-group>
<ref-list>
<ref id="bib1">
<mixed-citation publication-type="book">Shaffer D, Campbell M, Bradley SJ, Cantwell DP, Carlson GA, Cohen DJ et al. <article-title>Disorders usually first diagnosed in infancy, childhood, or
adolescence</article-title>. In: Ruth Ross, ed. <source/>Diagnostic and Statistical Manual of Mental Disorders: DSM-IV: International
Version with ICD-10 Codes M.A. American Psychiatric Association: Washington, DC, <year>1995</year>, pp <fpage>37</fpage>–121.</mixed-citation>
</ref>
<ref id="bib2">
<mixed-citation publication-type="journal">Musante L, Ropers HH. <article-title>Genetics of recessive cognitive disorders</article-title>. <source/>Trends Genet
<year>2014</year>; <volume>30</volume>: <fpage>32</fpage>–39.<pub-id pub-id-type="pmid">24176302</pub-id></mixed-citation>
</ref>
<ref id="bib3">
<mixed-citation publication-type="journal">Ropers HH. <article-title>Genetics of early onset cognitive impairment</article-title>. <source/>Annu Rev Genomics Hum Genet
<year>2010</year>; <volume>11</volume>: <fpage>161</fpage>–187.<pub-id pub-id-type="pmid">20822471</pub-id></mixed-citation>
</ref>
<ref id="bib4">
<mixed-citation publication-type="journal">Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S. <article-title>Prevalence of intellectual disability: a meta-analysis of population-based
studies</article-title>. <source/>Res Dev Disabil
<year>2011</year>; <volume>32</volume>: <fpage>419</fpage>–436.<pub-id pub-id-type="pmid">21236634</pub-id></mixed-citation>
</ref>
<ref id="bib5">
<mixed-citation publication-type="journal">Leonard H, Wen X. <article-title>The epidemiology of mental retardation: challenges and opportunities in the
new millennium</article-title>. <source/>Ment Retard Dev Disabil Res Rev
<year>2002</year>; <volume>8</volume>: <fpage>117</fpage>–134.<pub-id pub-id-type="pmid">12216056</pub-id></mixed-citation>
</ref>
<ref id="bib6">
<mixed-citation publication-type="journal">Molinari F, Foulquier F, Tarpey PS, Morelle W, Boissel S, Teague J et al. <article-title>Oligosaccharyltransferase-subunit mutations in nonsyndromic mental
retardation</article-title>. <source/>Am J Hum Genet
<year>2008</year>; <volume>82</volume>: <fpage>1150</fpage>–1157.<pub-id pub-id-type="pmid">18455129</pub-id></mixed-citation>
</ref>
<ref id="bib7">
<mixed-citation publication-type="journal">Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH et al. <article-title>Genome sequencing identifies major causes of severe intellectual
disability</article-title>. <source/>Nature
<year>2014</year>; <volume>511</volume>: <fpage>344</fpage>–347.<pub-id pub-id-type="pmid">24896178</pub-id></mixed-citation>
</ref>
<ref id="bib8">
<mixed-citation publication-type="journal">Basel-Vanagaite L, Attia R, Yahav M, Ferland RJ, Anteki L, Walsh CA et al. <article-title>The CC2D1A, a member of a new gene family with C2 domains, is involved in
autosomal recessive non-syndromic mental retardation</article-title>. <source/>J Med Genet
<year>2006</year>; <volume>43</volume>: <fpage>203</fpage>–210.<pub-id pub-id-type="pmid">16033914</pub-id></mixed-citation>
</ref>
<ref id="bib9">
<mixed-citation publication-type="journal">Higgins JJ, Pucilowska J, Lombardi RQ, Rooney JP. <article-title>A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild
mental retardation</article-title>. <source/>Neurology
<year>2004</year>; <volume>63</volume>: <fpage>1927</fpage>–1931.<pub-id pub-id-type="pmid">15557513</pub-id></mixed-citation>
</ref>
<ref id="bib10">
<mixed-citation publication-type="journal">Molinari F, Rio M, Meskenaite V, Encha-Razavi F, Auge J, Bacq D et al. <article-title>Truncating neurotrypsin mutation in autosomal recessive nonsyndromic mental
retardation</article-title>. <source/>Science
<year>2002</year>; <volume>298</volume>: <fpage>1779</fpage>–1781.<pub-id pub-id-type="pmid">12459588</pub-id></mixed-citation>
</ref>
<ref id="bib11">
<mixed-citation publication-type="journal">Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W et al. <article-title>Deep sequencing reveals 50 novel genes for recessive cognitive
disorders</article-title>. <source/>Nature
<year>2011</year>; <volume>478</volume>: <fpage>57</fpage>–63.<pub-id pub-id-type="pmid">21937992</pub-id></mixed-citation>
</ref>
<ref id="bib12">
<mixed-citation publication-type="journal">Alazami AM, Patel N, Shamseldin HE, Anazi S, Al-Dosari MS, Alzahrani F et al. <article-title>Accelerating novel candidate gene discovery in neurogenetic disorders via
whole-exome sequencing of prescreened multiplex consanguineous families</article-title>. <source/>Cell Rep
<year>2015</year>; <volume>10</volume>: <fpage>148</fpage>–161.<pub-id pub-id-type="pmid">25558065</pub-id></mixed-citation>
</ref>
<ref id="bib13">
<mixed-citation publication-type="journal">Hosseini-Chavoshi M, Abbasi-Shavazi MJ, Bittles AH. <article-title>Consanguineous marriage, reproductive behaviour and postnatal mortality in
contemporary Iran</article-title>. <source/>Hum Hered
<year>2014</year>; <volume>77</volume>: <fpage>16</fpage>–25.<pub-id pub-id-type="pmid">25060266</pub-id></mixed-citation>
</ref>
<ref id="bib14">
<mixed-citation publication-type="journal">Saadat M, Ansari-Lari M, Farhud DD. <article-title>Consanguineous marriage in Iran</article-title>. <source/>Ann Hum Biol
<year>2004</year>; <volume>31</volume>: <fpage>263</fpage>–269.<pub-id pub-id-type="pmid">15204368</pub-id></mixed-citation>
</ref>
<ref id="bib15">
<mixed-citation publication-type="journal">Bittles AH, Black ML. <article-title>The impact of consanguinity on neonatal and infant health</article-title>. <source/>Early Hum Dev
<year>2010</year>; <volume>86</volume>: <fpage>737</fpage>–741.<pub-id pub-id-type="pmid">20832202</pub-id></mixed-citation>
</ref>
<ref id="bib16">
<mixed-citation publication-type="journal">Iqbal Z, van Bokhoven H. <article-title>Identifying genes responsible for intellectual disability in consanguineous
families</article-title>. <source/>Hum Hered
<year>2014</year>; <volume>77</volume>: <fpage>150</fpage>–160.<pub-id pub-id-type="pmid">25060278</pub-id></mixed-citation>
</ref>
<ref id="bib17">
<mixed-citation publication-type="journal">Gustavson KH. <article-title>Prevalence and aetiology of congenital birth defects, infant mortality and
mental retardation in Lahore, Pakistan: a prospective cohort study</article-title>. <source/>Acta Paediatr
<year>2005</year>; <volume>94</volume>: <fpage>769</fpage>–774.<pub-id pub-id-type="pmid">16188785</pub-id></mixed-citation>
</ref>
<ref id="bib18">
<mixed-citation publication-type="journal">Zhang X, Snijders A, Segraves R, Zhang X, Niebuhr A, Albertson D et al. <article-title>High-resolution mapping of genotype-phenotype relationships in cri du chat
syndrome using array comparative genomic hybridization</article-title>. <source/>Am J Hum Genet
<year>2005</year>; <volume>76</volume>: <fpage>312</fpage>–326.<pub-id pub-id-type="pmid">15635506</pub-id></mixed-citation>
</ref>
<ref id="bib19">
<mixed-citation publication-type="journal">Grimberg J, Nawoschik S, Belluscio L, McKee R, Turck A, Eisenberg A. <article-title>A simple and efficient non-organic procedure for the isolation of genomic
DNA from blood</article-title>. <source/>Nucleic Acids Res
<year>1989</year>; <volume>17</volume>: <fpage>8390</fpage>.<pub-id pub-id-type="pmid">2813076</pub-id></mixed-citation>
</ref>
<ref id="bib20">
<mixed-citation publication-type="journal">Simon M, Richard EM, Wang X, Shahzad M, Huang VH, Qaiser TA et al. <article-title>Mutations of human NARS2, encoding the mitochondrial asparaginyl-tRNA
synthetase, cause nonsyndromic deafness and Leigh syndrome</article-title>. <source/>PLoS Genet
<year>2015</year>; <volume>11</volume>: <fpage>e1005097</fpage>.<pub-id pub-id-type="pmid">25807530</pub-id></mixed-citation>
</ref>
<ref id="bib21">
<mixed-citation publication-type="journal">Koressaar T, Remm M. <article-title>Enhancements and modifications of primer design program Primer3</article-title>. <source/>Bioinformatics
<year>2007</year>; <volume>23</volume>: <fpage>1289</fpage>–1291.<pub-id pub-id-type="pmid">17379693</pub-id></mixed-citation>
</ref>
<ref id="bib22">
<mixed-citation publication-type="journal">Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J et al. <article-title>STRING v10: protein-protein interaction networks, integrated over the tree
of life</article-title>. <source/>Nucleic Acids Res
<year>2015</year>; <volume>43</volume>: <fpage>D447</fpage>–D452.<pub-id pub-id-type="pmid">25352553</pub-id></mixed-citation>
</ref>
<ref id="bib23">
<mixed-citation publication-type="journal">Ulitsky I, Shamir R. <article-title>Identification of functional modules using network topology and
high-throughput data</article-title>. <source/>BMC Syst Biol
<year>2007</year>; <volume>1</volume>: <fpage>8</fpage>.<pub-id pub-id-type="pmid">17408515</pub-id></mixed-citation>
</ref>
<ref id="bib24">
<mixed-citation publication-type="journal">Ulitsky I, Maron-Katz A, Shavit S, Sagir D, Linhart C, Elkon R et al. <article-title>Expander: from expression microarrays to networks and functions</article-title>. <source/>Nat Protoc
<year>2010</year>; <volume>5</volume>: <fpage>303</fpage>–322.<pub-id pub-id-type="pmid">20134430</pub-id></mixed-citation>
</ref>
<ref id="bib25">
<mixed-citation publication-type="journal">Miller JA, Ding SL, Sunkin SM, Smith KA, Ng L, Szafer A et al. <article-title>Transcriptional landscape of the prenatal human brain</article-title>. <source/>Nature
<year>2014</year>; <volume>508</volume>: <fpage>199</fpage>–206.<pub-id pub-id-type="pmid">24695229</pub-id></mixed-citation>
</ref>
<ref id="bib26">
<mixed-citation publication-type="journal">Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S et al. <article-title>Spatial and temporal mapping of de novo mutations in schizophrenia to a
fetal prefrontal cortical network</article-title>. <source/>Cell
<year>2013</year>; <volume>154</volume>: <fpage>518</fpage>–529.<pub-id pub-id-type="pmid">23911319</pub-id></mixed-citation>
</ref>
<ref id="bib27">
<mixed-citation publication-type="other">Exome Aggregation Consortium (ExAC) C, MA. Available at http://exac.broadinstitute.org (accessed on 15 January 2015).</mixed-citation>
</ref>
<ref id="bib28">
<mixed-citation publication-type="journal">Jordan DM, Frangakis SG, Golzio C, Cassa CA, Kurtzberg J et alTask Force for Neonatal G. <article-title>Identification of cis-suppression of human disease mutations by comparative
genomics</article-title>. <source/>Nature
<year>2015</year>; <volume>524</volume>: <fpage>225</fpage>–229.<pub-id pub-id-type="pmid">26123021</pub-id></mixed-citation>
</ref>
<ref id="bib29">
<mixed-citation publication-type="journal">Vu V, Verster AJ, Schertzberg M, Chuluunbaatar T, Spensley M, Pajkic D et al. <article-title>Natural variation in gene expression modulates the severity of mutant
phenotypes</article-title>. <source/>Cell
<year>2015</year>; <volume>162</volume>: <fpage>391</fpage>–402.<pub-id pub-id-type="pmid">26186192</pub-id></mixed-citation>
</ref>
<ref id="bib30">
<mixed-citation publication-type="journal">Reese MG, Eeckman FH, Kulp D, Haussler D. <article-title>Improved splice site detection in Genie</article-title>. <source/>J Comput Biol
<year>1997</year>; <volume>4</volume>: <fpage>311</fpage>–323.<pub-id pub-id-type="pmid">9278062</pub-id></mixed-citation>
</ref>
<ref id="bib31">
<mixed-citation publication-type="journal">Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. <article-title>Human Splicing Finder: an online bioinformatics tool to predict splicing
signals</article-title>. <source/>Nucleic Acids Res
<year>2009</year>; <volume>37</volume>: <fpage>e67</fpage>.<pub-id pub-id-type="pmid">19339519</pub-id></mixed-citation>
</ref>
<ref id="bib32">
<mixed-citation publication-type="journal">Yeo G, Burge CB. <article-title>Maximum entropy modeling of short sequence motifs with applications to RNA
splicing signals</article-title>. <source/>J Comput Biol
<year>2004</year>; <volume>11</volume>: <fpage>377</fpage>–394.<pub-id pub-id-type="pmid">15285897</pub-id></mixed-citation>
</ref>
<ref id="bib33">
<mixed-citation publication-type="journal">Jimenez-Marin A, Collado-Romero M, Ramirez-Boo M, Arce C, Garrido JJ. <article-title>Biological pathway analysis by ArrayUnlock and Ingenuity Pathway
Analysis</article-title>. <source/>BMC Proc
<year>2009</year>; <volume>3</volume>(Suppl 4): <fpage>S6</fpage>.</mixed-citation>
</ref>
<ref id="bib34">
<mixed-citation publication-type="journal">Viggiano A, Cacciola G, Widmer DA, Viggiano D. <article-title>Anxiety as a neurodevelopmental disorder in a neuronal subpopulation:
evidence from gene expression data</article-title>. <source/>Psychiatry Res
<year>2015</year>; <volume>228</volume>: <fpage>729</fpage>–740.<pub-id pub-id-type="pmid">26089015</pub-id></mixed-citation>
</ref>
<ref id="bib35">
<mixed-citation publication-type="journal">Loucks CM, Parboosingh JS, Shaheen R, Bernier FP, McLeod DR, Seidahmed MZ et al. <article-title>Matching two independent cohorts validates DPH1 as a gene responsible for
autosomal recessive intellectual disability with short stature, craniofacial,
and ectodermal anomalies</article-title>. <source/>Hum Mutat
<year>2015</year>; <volume>36</volume>: <fpage>1015</fpage>–1019.<pub-id pub-id-type="pmid">26220823</pub-id></mixed-citation>
</ref>
<ref id="bib36">
<mixed-citation publication-type="journal">Kremer LS, Distelmaier F, Alhaddad B, Hempel M, Iuso A, Kupper C et al. <article-title>Bi-allelic Truncating Mutations in TANGO2 Cause Infancy-Onset Recurrent
Metabolic Crises with Encephalocardiomyopathy</article-title>. <source/>Am J Hum Genet
<year>2016</year>; <volume>98</volume>: <fpage>358</fpage>–362.<pub-id pub-id-type="pmid">26805782</pub-id></mixed-citation>
</ref>
<ref id="bib37">
<mixed-citation publication-type="journal">Lalani SR, Liu P, Rosenfeld JA, Watkin LB, Chiang T, Leduc MS et al. <article-title>Recurrent muscle weakness with rhabdomyolysis, metabolic crises, and cardiac
arrhythmia due to bi-allelic TANGO2 mutations</article-title>. <source/>Am J Hum Genet
<year>2016</year>; <volume>98</volume>: <fpage>347</fpage>–357.<pub-id pub-id-type="pmid">26805781</pub-id></mixed-citation>
</ref>
<ref id="bib38">
<mixed-citation publication-type="journal">Narasimhan VM, Hunt KA, Mason D, Baker CL, Karczewski KJ, Barnes MR et al. <article-title>Health and population effects of rare gene knockouts in adult humans with
related parents</article-title>. <source/>Science
<year>2016</year>; <volume>352</volume>: <fpage>474</fpage>–477.<pub-id pub-id-type="pmid">26940866</pub-id></mixed-citation>
</ref>
<ref id="bib39">
<mixed-citation publication-type="journal">Ferland RJ, Eyaid W, Collura RV, Tully LD, Hill RS, Al-Nouri D et al. <article-title>Abnormal cerebellar development and axonal decussation due to mutations in
AHI1 in Joubert syndrome</article-title>. <source/>Nat Genet
<year>2004</year>; <volume>36</volume>: <fpage>1008</fpage>–1013.<pub-id pub-id-type="pmid">15322546</pub-id></mixed-citation>
</ref>
<ref id="bib40">
<mixed-citation publication-type="journal">Zahrani F, Aldahmesh MA, Alshammari MJ, Al-Hazzaa SA, Alkuraya FS. <article-title>Mutations in c12orf57 cause a syndromic form of colobomatous
microphthalmia</article-title>. <source/>Am J Hum Genet
<year>2013</year>; <volume>92</volume>: <fpage>387</fpage>–391.<pub-id pub-id-type="pmid">23453665</pub-id></mixed-citation>
</ref>
<ref id="bib41">
<mixed-citation publication-type="journal">Yoshida A, Kobayashi K, Manya H, Taniguchi K, Kano H, Mizuno M et al. <article-title>Muscular dystrophy and neuronal migration disorder caused by mutations in a
glycosyltransferase, POMGnT1</article-title>. <source/>Dev Cell
<year>2001</year>; <volume>1</volume>: <fpage>717</fpage>–724.<pub-id pub-id-type="pmid">11709191</pub-id></mixed-citation>
</ref>
<ref id="bib42">
<mixed-citation publication-type="journal">Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G et al. <article-title>Connexin 26 mutations in hereditary non-syndromic sensorineural
deafness</article-title>. <source/>Nature
<year>1997</year>; <volume>387</volume>: <fpage>80</fpage>–83.<pub-id pub-id-type="pmid">9139825</pub-id></mixed-citation>
</ref>
<ref id="bib43">
<mixed-citation publication-type="journal">Robertson NG, Lu L, Heller S, Merchant SN, Eavey RD, McKenna M et al. <article-title>Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic
deafness with vestibular dysfunction</article-title>. <source/>Nat Genet
<year>1998</year>; <volume>20</volume>: <fpage>299</fpage>–303.<pub-id pub-id-type="pmid">9806553</pub-id></mixed-citation>
</ref>
<ref id="bib44">
<mixed-citation publication-type="journal">Walsh T, Walsh V, Vreugde S, Hertzano R, Shahin H, Haika S et al. <article-title>From flies’ eyes to our ears: mutations in a human class III myosin
cause progressive nonsyndromic hearing loss DFNB30</article-title>. <source/>Proc Natl Acad Sci USA
<year>2002</year>; <volume>99</volume>: <fpage>7518</fpage>–7523.<pub-id pub-id-type="pmid">12032315</pub-id></mixed-citation>
</ref>
<ref id="bib45">
<mixed-citation publication-type="journal">Chen R, Shi L, Hakenberg J, Naughton B, Sklar P, Zhang J et al. <article-title>Analysis of 589,306 genomes identifies individuals resilient to severe
Mendelian childhood diseases</article-title>. <source/>Nat Biotechnol
<year>2016</year>; <volume>34</volume>: <fpage>531</fpage>–538.<pub-id pub-id-type="pmid">27065010</pub-id></mixed-citation>
</ref>
<ref id="bib46">
<mixed-citation publication-type="journal">Riazuddin S, Castelein CM, Ahmed ZM, Lalwani AK, Mastroianni MA, Naz S et al. <article-title>Dominant modifier DFNM1 suppresses recessive deafness DFNB26</article-title>. <source/>Nat Genet
<year>2000</year>; <volume>26</volume>: <fpage>431</fpage>–434.<pub-id pub-id-type="pmid">11101839</pub-id></mixed-citation>
</ref>
<ref id="bib47">
<mixed-citation publication-type="journal">Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A et al. <article-title>Sequencing chromosomal abnormalities reveals neurodevelopmental loci that
confer risk across diagnostic boundaries</article-title>. <source/>Cell
<year>2012</year>; <volume>149</volume>: <fpage>525</fpage>–537.<pub-id pub-id-type="pmid">22521361</pub-id></mixed-citation>
</ref>
<ref id="bib48">
<mixed-citation publication-type="journal">van Bokhoven H. <article-title>Genetic and epigenetic networks in intellectual disabilities</article-title>. <source/>Annu Rev Genet
<year>2011</year>; <volume>45</volume>: <fpage>81</fpage>–104.<pub-id pub-id-type="pmid">21910631</pub-id></mixed-citation>
</ref>
<ref id="bib49">
<mixed-citation publication-type="journal">Adam D. <article-title>Mental health: on the spectrum</article-title>. <source/>Nature
<year>2013</year>; <volume>496</volume>: <fpage>416</fpage>–418.<pub-id pub-id-type="pmid">23619674</pub-id></mixed-citation>
</ref>
<ref id="bib50">
<mixed-citation publication-type="journal">Mullin AP, Gokhale A, Moreno-De-Luca A, Sanyal S, Waddington JL, Faundez V. <article-title>Neurodevelopmental disorders: mechanisms and boundary definitions from
genomes, interactomes and proteomes</article-title>. <source/>Transl Psychiatry
<year>2013</year>; <volume>3</volume>: <fpage>e329</fpage>.<pub-id pub-id-type="pmid">24301647</pub-id></mixed-citation>
</ref>
<ref id="bib51">
<mixed-citation publication-type="journal">McCarthy SE, Gillis J, Kramer M, Lihm J, Yoon S, Berstein Y et al. <article-title>De novo mutations in schizophrenia implicate chromatin remodeling and
support a genetic overlap with autism and intellectual disability</article-title>. <source/>Mol Psychiatry
<year>2014</year>; <volume>19</volume>: <fpage>652</fpage>–658.<pub-id pub-id-type="pmid">24776741</pub-id></mixed-citation>
</ref>
<ref id="bib52">
<mixed-citation publication-type="journal">De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE et al. <article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>. <source/>Nature
<year>2014</year>; <volume>515</volume>: <fpage>209</fpage>–215.<pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="bib53">
<mixed-citation publication-type="journal">Berg AT, Plioplys S. <article-title>Epilepsy and autism: is there a special relationship</article-title>? <source/>Epilepsy Behav
<year>2012</year>; <volume>23</volume>: <fpage>193</fpage>–198.<pub-id pub-id-type="pmid">22381386</pub-id></mixed-citation>
</ref>
<ref id="bib54">
<mixed-citation publication-type="journal">Prince E, Ring H. <article-title>Causes of learning disability and epilepsy: a review</article-title>. <source/>Curr Opin Neurol
<year>2011</year>; <volume>24</volume>: <fpage>154</fpage>–158.<pub-id pub-id-type="pmid">21293271</pub-id></mixed-citation>
</ref>
<ref id="bib55">
<mixed-citation publication-type="journal">Syrbe S, Hedrich UB, Riesch E, Djemie T, Muller S, Moller RS et al. <article-title>De novo loss- or gain-of-function mutations in KCNA2 cause epileptic
encephalopathy</article-title>. <source/>Nat Genet
<year>2015</year>; <volume>47</volume>: <fpage>393</fpage>–399.<pub-id pub-id-type="pmid">25751627</pub-id></mixed-citation>
</ref>
<ref id="bib56">
<mixed-citation publication-type="journal">Pena SD, Coimbra RL. <article-title>Ataxia and myoclonic epilepsy due to a heterozygous new mutation in KCNA2:
proposal for a new channelopathy</article-title>. <source/>Clin Genet
<year>2015</year>; <volume>87</volume>: <fpage>e1</fpage>–e3.<pub-id pub-id-type="pmid">25477152</pub-id></mixed-citation>
</ref>
<ref id="bib57">
<mixed-citation publication-type="journal">Abu-Akel A, Shamay-Tsoory S. <article-title>Neuroanatomical and neurochemical bases of theory of mind</article-title>. <source/>Neuropsychologia
<year>2011</year>; <volume>49</volume>: <fpage>2971</fpage>–2984.<pub-id pub-id-type="pmid">21803062</pub-id></mixed-citation>
</ref>
<ref id="bib58">
<mixed-citation publication-type="journal">Gemelli T, Berton O, Nelson ED, Perrotti LI, Jaenisch R, Monteggia LM. <article-title>Postnatal loss of methyl-CpG binding protein 2 in the forebrain is
sufficient to mediate behavioral aspects of Rett syndrome in mice</article-title>. <source/>Biol Psychiatry
<year>2006</year>; <volume>59</volume>: <fpage>468</fpage>–476.<pub-id pub-id-type="pmid">16199017</pub-id></mixed-citation>
</ref>
<ref id="bib59">
<mixed-citation publication-type="journal">Schaefer A, Sampath SC, Intrator A, Min A, Gertler TS, Surmeier DJ et al. <article-title>Control of cognition and adaptive behavior by the GLP/G9a epigenetic
suppressor complex</article-title>. <source/>Neuron
<year>2009</year>; <volume>64</volume>: <fpage>678</fpage>–691.<pub-id pub-id-type="pmid">20005824</pub-id></mixed-citation>
</ref>
<ref id="bib60">
<mixed-citation publication-type="journal">Berry-Kravis E. <article-title>Mechanism-based treatments in neurodevelopmental disorders: fragile X
syndrome</article-title>. <source/>Pediatr Neurol
<year>2014</year>; <volume>50</volume>: <fpage>297</fpage>–302.<pub-id pub-id-type="pmid">24518745</pub-id></mixed-citation>
</ref>
<ref id="bib61">
<mixed-citation publication-type="journal">Gardiner KJ. <article-title>Pharmacological approaches to improving cognitive function in Down syndrome:
current status and considerations</article-title>. <source/>Drug Des Devel Ther
<year>2015</year>; <volume>9</volume>: <fpage>103</fpage>–125.</mixed-citation>
</ref>
<ref id="bib62">
<mixed-citation publication-type="journal">van der Vaart T, Plasschaert E, Rietman AB, Renard M, Oostenbrink R, Vogels A et al. <article-title>Simvastatin for cognitive deficits and behavioural problems in patients with
neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled
trial</article-title>. <source/>Lancet Neurol
<year>2013</year>; <volume>12</volume>: <fpage>1076</fpage>–1083.<pub-id pub-id-type="pmid">24090588</pub-id></mixed-citation>
</ref>
<ref id="bib63">
<mixed-citation publication-type="journal">Mabb AM, Ehlers MD. <article-title>Ubiquitination in postsynaptic function and plasticity</article-title>. <source/>Annu Rev Cell Dev Biol
<year>2010</year>; <volume>26</volume>: <fpage>179</fpage>–210.<pub-id pub-id-type="pmid">20604708</pub-id></mixed-citation>
</ref>
<ref id="bib64">
<mixed-citation publication-type="journal">Hegde AN, Upadhya SC. <article-title>Role of ubiquitin-proteasome-mediated proteolysis in nervous system
disease</article-title>. <source/>Biochim Biophys Acta
<year>2011</year>; <volume>1809</volume>: <fpage>128</fpage>–140.<pub-id pub-id-type="pmid">20674814</pub-id></mixed-citation>
</ref>
</ref-list>
<sec id="sup1" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="xob1">
<label>Supplementary Information</label>
<media xlink:href="mp2016109x1.doc" xmlns:xlink="http://www.w3.org/1999/xlink">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="xob2">
<label>Supplementary Tables</label>
<media xlink:href="mp2016109x2.doc" xmlns:xlink="http://www.w3.org/1999/xlink">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="xob3">
<label>Supplementary Table 3</label>
<media xlink:href="mp2016109x3.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="xob4">
<label>Supplementary Table 8</label>
<media xlink:href="mp2016109x4.xls" xmlns:xlink="http://www.w3.org/1999/xlink">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="xob5">
<label>Supplementary Figures</label>
<media xlink:href="mp2016109x5.doc" xmlns:xlink="http://www.w3.org/1999/xlink">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="xob6">
<label>Supplementary Table and Figure Legends</label>
<media xlink:href="mp2016109x6.docx" xmlns:xlink="http://www.w3.org/1999/xlink">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</back>
<floats-group>
<fig id="fig1">
<label>Figure 1</label>
<caption>
<p>(<bold>a</bold>) Protein–protein interactions of novel candidates in
different pathways. Novel candidate genes either directly interact with
known intellectual disability (ID) genes (in blue) or through other genes
(in gray) in the pathway. (<bold>b</bold>) Molecular functions of novel candidate
genes (in red) for ID are indicated. Genes are involved in various cellular
processes by activating, inhibiting and interacting with other molecules and
are part of protein complexes.</p>
</caption>
<graphic xlink:href="mp2016109f1" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<fig id="fig2">
<label>Figure 2</label>
<caption>
<p>Co-expression of novel intellectual disability (ID) candidate genes was
evaluated using RNA-seq data from the BrainSpan Atlas. (<bold>a</bold>) Gene pairs
were defined as connected if the absolute value of the Pearson’s
correlation coefficient is &gt;0.8 for their expression levels in different
brain region (frontal cortex, temporal–parietal, sensory–motor
and sub-cortical) and different developmental stage (fetal, infancy to late
childhood and adolescence to adulthood). Connections of co-expression genes
at three development stages and four brain regions were plotted. Dotted
lines indicate numbers of connections (edges) in networks created using
target genes. Histograms represent distributions of the numbers of edges in
10 000 simulated networks using a similar number of random genes.
*Represents the significance enrichment with <italic>P</italic> less than
adjusted <italic>P</italic>-value. <bold>(b)</bold> Co-expression of novel ID candidate
genes during embryonic developmental stages for the same four brain
regions.</p>
</caption>
<graphic xlink:href="mp2016109f2" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<fig id="fig3">
<label>Figure 3</label>
<caption>
<p>Overview of the results of genetic studies in 121 consanguineous Pakistani
families segregating recessive intellectual disability (ID) phenotype.</p>
</caption>
<graphic xlink:href="mp2016109f3" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
<table-wrap id="tbl1">
<label>Table 1</label>
<caption>
<title>Variants identified in known genes for intellectual disability or related
disorders</title>
</caption>
<table border="1" frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="center"/>
</colgroup>
<thead valign="bottom">
<tr>
<th align="left" charoff="50" valign="top">
<italic>Family</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Gene</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Position</italic>
<xref ref-type="fn" rid="t1-fn2">a</xref>
</th>
<th align="left" charoff="50" valign="top">
<italic>Transcript</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>cDNA mutation</italic>
<xref ref-type="fn" rid="t1-fn3">b</xref>
</th>
<th align="left" charoff="50" valign="top">
<italic>Protein change</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Variation</italic>
</th>
<th align="center" charoff="50" valign="top">
<italic>CADD score v1.3</italic>
</th>
<th align="center" char="." charoff="50" valign="top">
<italic>ExAC allele frequency x10</italic>
<sup>−<italic>6</italic></sup>
</th>
<th align="center" char="." charoff="50" valign="top">
<italic>OMIM</italic>
</th>
<th align="center" charoff="50" valign="top">
<italic>Phenotype</italic>
<xref ref-type="fn" rid="t1-fn4">c</xref>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" charoff="50" valign="top">PKMR08</td>
<td align="left" charoff="50" valign="top">
<italic>GNE</italic>
</td>
<td align="left" charoff="50" valign="top">Chr9:36217445C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_005476.5</td>
<td align="left" charoff="50" valign="top">c.2086G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Val696Met)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">32.0</td>
<td align="char" char="." charoff="50" valign="top">1942</td>
<td align="char" char="." charoff="50" valign="top">603824</td>
<td align="center" charoff="50" valign="top">D</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR29</td>
<td align="left" charoff="50" valign="top">
<italic>POMT2</italic>
</td>
<td align="left" charoff="50" valign="top">Chr14:77765840T&gt;C</td>
<td align="left" charoff="50" valign="top">NM_013382.5</td>
<td align="left" charoff="50" valign="top">c.881A&gt;G</td>
<td align="left" charoff="50" valign="top">p.(Tyr294Cys)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">27.9</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">607439</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR36</td>
<td align="left" charoff="50" valign="top">
<italic>APTX</italic>
</td>
<td align="left" charoff="50" valign="top">Chr9:32984803delC</td>
<td align="left" charoff="50" valign="top">NM_001195248.1</td>
<td align="left" charoff="50" valign="top">c.638delG</td>
<td align="left" charoff="50" valign="top">p.(Arg213Leufs*15)</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">8.238</td>
<td align="char" char="." charoff="50" valign="top">606350</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR42</td>
<td align="left" charoff="50" valign="top">
<italic>VPS13B</italic>
</td>
<td align="left" charoff="50" valign="top">Chr8:100654333C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_017890.4</td>
<td align="left" charoff="50" valign="top">c.5590C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Gln1864*)</td>
<td align="left" charoff="50" valign="top">Nonsense</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">607817</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR51a</td>
<td align="left" charoff="50" valign="top">
<italic>TSHR</italic>
</td>
<td align="left" charoff="50" valign="top">Chr14:81610687C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_000369.2</td>
<td align="left" charoff="50" valign="top">
<bold>c.2285C&gt;T</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Thr762Met)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">25.3</td>
<td align="char" char="." charoff="50" valign="top">8.247</td>
<td align="char" char="." charoff="50" valign="top">603372</td>
<td align="center" charoff="50" valign="top">D</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR61a</td>
<td align="left" charoff="50" valign="top">
<italic>SCN1A</italic>
</td>
<td align="left" charoff="50" valign="top">Chr2:166848284G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_001165963.1</td>
<td align="left" charoff="50" valign="top">c.5501C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Ala1834Val)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">32</td>
<td align="char" char="." charoff="50" valign="top">8.241</td>
<td align="char" char="." charoff="50" valign="top">182389<xref ref-type="fn" rid="t1-fn5">d</xref></td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR79</td>
<td align="left" charoff="50" valign="top">
<italic>AP4M1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr7:99704430delG</td>
<td align="left" charoff="50" valign="top">NM_004722.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.1287delG</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Arg429Serfs*15)</bold>
</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">602296</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR82</td>
<td align="left" charoff="50" valign="top">
<italic>KCNA2</italic>
</td>
<td align="left" charoff="50" valign="top">Chr1:111147212G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_004974.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.193C&gt;T</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Arg65*)</bold>
</td>
<td align="left" charoff="50" valign="top">Nonsense</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">8.239</td>
<td align="char" char="." charoff="50" valign="top">176262<xref ref-type="fn" rid="t1-fn5">d</xref></td>
<td align="center" charoff="50" valign="top">C, inheritance D</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR85</td>
<td align="left" charoff="50" valign="top">
<italic>MED23</italic>
</td>
<td align="left" charoff="50" valign="top">Chr6:131941859T&gt;C</td>
<td align="left" charoff="50" valign="top">NM_004830.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.506A&gt;G</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Tyr169Cys)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">24.6</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">605042</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR86</td>
<td align="left" charoff="50" valign="top">
<italic>FRAS1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr4:79202579C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_025074.6</td>
<td align="left" charoff="50" valign="top">
<bold>c.1099C&gt;T</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Arg367Cys)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">24.4</td>
<td align="char" char="." charoff="50" valign="top">43.14</td>
<td align="char" char="." charoff="50" valign="top">607830</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR87</td>
<td align="left" charoff="50" valign="top">
<italic>MAN2B1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr19:12763176C&gt;G</td>
<td align="left" charoff="50" valign="top">NM_000528.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.1928+1C&gt;G</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Phe642Phefs*2)</bold>
</td>
<td align="left" charoff="50" valign="top">Aberrant splicing</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">609458</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR97</td>
<td align="left" charoff="50" valign="top">
<italic>MFSD2A</italic>
</td>
<td align="left" charoff="50" valign="top">Chr1:40431565C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_001136493.2</td>
<td align="left" charoff="50" valign="top">
<bold>c.632C&gt;T</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Thr211Met)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">33</td>
<td align="char" char="." charoff="50" valign="top">8.239</td>
<td align="char" char="." charoff="50" valign="top">614397</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR99</td>
<td align="left" charoff="50" valign="top">
<italic>SYNE1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr6:152819877C&gt;G</td>
<td align="left" charoff="50" valign="top">NM_182961.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.939G&gt;C</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Lys313Asn)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">21.9</td>
<td align="char" char="." charoff="50" valign="top">28.33</td>
<td align="char" char="." charoff="50" valign="top">608441</td>
<td align="center" charoff="50" valign="top">D</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR102</td>
<td align="left" charoff="50" valign="top">
<italic>ASPM</italic>
</td>
<td align="left" charoff="50" valign="top">Chr1:197087007C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_018136.4</td>
<td align="left" charoff="50" valign="top">
<bold>c.3977G&gt;A</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Trp1326*)</bold>
</td>
<td align="left" charoff="50" valign="top">Nonsense</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">8.255</td>
<td align="char" char="." charoff="50" valign="top">605481</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR105</td>
<td align="left" charoff="50" valign="top">
<italic>ZNF41</italic>
</td>
<td align="left" charoff="50" valign="top">ChrX:47315776C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_007130.2</td>
<td align="left" charoff="50" valign="top">
<bold>c.94G&gt;A</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Val32Met)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">30</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">314995</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR115</td>
<td align="left" charoff="50" valign="top">
<italic>SRD5A3</italic>
</td>
<td align="left" charoff="50" valign="top">Chr4:56212560G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_024592.4</td>
<td align="left" charoff="50" valign="top">c.57G&gt;A</td>
<td align="left" charoff="50" valign="top">p.Trp19*</td>
<td align="left" charoff="50" valign="top">Nonsense</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">357.1</td>
<td align="char" char="." charoff="50" valign="top">611715</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR119</td>
<td align="left" charoff="50" valign="top">
<italic>PGAP1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr2:197710616T&gt;C</td>
<td align="left" charoff="50" valign="top">NM_024989.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.2276A&gt;G</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Tyr759Cys)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">23.6</td>
<td align="char" char="." charoff="50" valign="top">16.57</td>
<td align="char" char="." charoff="50" valign="top">611655</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR133</td>
<td align="left" charoff="50" valign="top">
<italic>DOCK8</italic>
</td>
<td align="left" charoff="50" valign="top">Chr9:286599G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_203447.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.295G&gt;A</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Glu99Lys)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">25.9</td>
<td align="char" char="." charoff="50" valign="top">247.3</td>
<td align="char" char="." charoff="50" valign="top">611432</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR151</td>
<td align="left" charoff="50" valign="top">
<italic>TMEM67</italic>
</td>
<td align="left" charoff="50" valign="top">Chr8:94768056G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_153704.5</td>
<td align="left" charoff="50" valign="top">c.274G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Gly92Arg)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">25.6</td>
<td align="char" char="." charoff="50" valign="top">17.41</td>
<td align="char" char="." charoff="50" valign="top">609884</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR152</td>
<td align="left" charoff="50" valign="top">
<italic>WDR62</italic>
</td>
<td align="left" charoff="50" valign="top">Chr19:36587982G&gt;T</td>
<td align="left" charoff="50" valign="top">NM_001083961.1</td>
<td align="left" charoff="50" valign="top">
<bold>c.2520+1G&gt;T</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Leu840Leufs*95)</bold>
</td>
<td align="left" charoff="50" valign="top">Aberrant splicing</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">613583</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR184</td>
<td align="left" charoff="50" valign="top">
<italic>SPG11</italic>
</td>
<td align="left" charoff="50" valign="top">Chr15:44876109delA</td>
<td align="left" charoff="50" valign="top">NM_025137.3</td>
<td align="left" charoff="50" valign="top">c.5769delT</td>
<td align="left" charoff="50" valign="top">p.(Ser1923Argfs*28)</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">41.18</td>
<td align="char" char="." charoff="50" valign="top">610844</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR188</td>
<td align="left" charoff="50" valign="top">
<italic>ASPA</italic>
</td>
<td align="left" charoff="50" valign="top">Chr17:3402260G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_000049.2</td>
<td align="left" charoff="50" valign="top">c.820G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Gly274Arg)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">28.9</td>
<td align="char" char="." charoff="50" valign="top">8.421</td>
<td align="char" char="." charoff="50" valign="top">608034</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR193</td>
<td align="left" charoff="50" valign="top">
<italic>ARL13B</italic>
</td>
<td align="left" charoff="50" valign="top">Chr3:93755508G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_182896.2</td>
<td align="left" charoff="50" valign="top">
<bold>c.599G&gt;A</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Arg200His)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">34</td>
<td align="char" char="." charoff="50" valign="top">8.314</td>
<td align="char" char="." charoff="50" valign="top">608922</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR212</td>
<td align="left" charoff="50" valign="top">
<italic>ZFYVE26</italic>
</td>
<td align="left" charoff="50" valign="top">Chr14:68268804_05delGA</td>
<td align="left" charoff="50" valign="top">NM_015346.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.1630_1631delTC</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Ser544Leufs*24)</bold>
</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">8.236</td>
<td align="char" char="." charoff="50" valign="top">612012</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR216</td>
<td align="left" charoff="50" valign="top">
<italic>AP4S1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr14:31539047A&gt;G</td>
<td align="left" charoff="50" valign="top">NM_007077.4</td>
<td align="left" charoff="50" valign="top">
<bold>c.139-2A&gt;G</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Gln46Glnfs*85)</bold>
</td>
<td align="left" charoff="50" valign="top">Aberrant splicing</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">24.71</td>
<td align="char" char="." charoff="50" valign="top">607243</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR224</td>
<td align="left" charoff="50" valign="top">
<italic>MKKS</italic>
</td>
<td align="left" charoff="50" valign="top">Chr20:10393388delT</td>
<td align="left" charoff="50" valign="top">NM_018848.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.775delA</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Thr259Leufs*21)</bold>
</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">74.18</td>
<td align="char" char="." charoff="50" valign="top">604896</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR242</td>
<td align="left" charoff="50" valign="top">
<italic>WDR73</italic>
</td>
<td align="left" charoff="50" valign="top">Chr15:85186864A&gt;G</td>
<td align="left" charoff="50" valign="top">NM_032856.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.974T&gt;C</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Phe325Ser)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">29.9</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">616144</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR264</td>
<td align="left" charoff="50" valign="top">
<italic>FRY</italic>
</td>
<td align="left" charoff="50" valign="top">Chr13:32747633G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_023037.2</td>
<td align="left" charoff="50" valign="top">
<bold>c.2281G&gt;A</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Val761Ile)</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">21.7</td>
<td align="char" char="." charoff="50" valign="top">8.281</td>
<td align="char" char="." charoff="50" valign="top">614818</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR281</td>
<td align="left" charoff="50" valign="top">
<italic>GPT2</italic>
</td>
<td align="left" charoff="50" valign="top">Chr16:46956326C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_133443.3</td>
<td align="left" charoff="50" valign="top">
<bold>c.1210C&gt;T</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.(Arg404*)</bold>
</td>
<td align="left" charoff="50" valign="top">Nonsense</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">33.31</td>
<td align="char" char="." charoff="50" valign="top">138210</td>
<td align="center" charoff="50" valign="top">O</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR321</td>
<td align="left" charoff="50" valign="top">
<italic>FLNA</italic>
</td>
<td align="left" charoff="50" valign="top">ChrX:153583356G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_001110556.1</td>
<td align="left" charoff="50" valign="top">
<bold>c.5054C&gt;T</bold>
</td>
<td align="left" charoff="50" valign="top">
<bold>p.Thr1685Met</bold>
</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="center" charoff="50" valign="top">27.1</td>
<td align="char" char="." charoff="50" valign="top">11.58</td>
<td align="char" char="." charoff="50" valign="top">300017</td>
<td align="center" charoff="50" valign="top">C</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t1-fn1">
<p>Abbreviations: C, concordant; D, discordant; NA, not applicable; O,
overlapping features.</p>
</fn>
<fn id="t1-fn2">
<label>a</label>
<p>Chromosomal position according to GRCh37/hg19.</p>
</fn>
<fn id="t1-fn3">
<label>b</label>
<p>Novel mutations are written in bold font.</p>
</fn>
<fn id="t1-fn4">
<label>c</label>
<p>Concordance of the observed phenotype with the phenotype reported in
Online Mendelian Inheritance in Man (OMIM).</p>
</fn>
<fn id="t1-fn5">
<label>d</label>
<p>Reported phenotypes show a dominant inheritance pattern, whereas the
mutations reported here are homozygous.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tbl2">
<label>Table 2</label>
<caption>
<title>Novel candidate genes for intellectual disability</title>
</caption>
<table border="1" frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="center"/>
<col align="char" char="."/>
</colgroup>
<thead valign="bottom">
<tr>
<th align="left" charoff="50" valign="top">
<italic>Family</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Ethnicity</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Genes</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Position</italic>
<xref ref-type="fn" rid="t2-fn2">a</xref>
</th>
<th align="left" charoff="50" valign="top">
<italic>Transcript</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>cDNA mutation</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Protein change</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Variation</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Protein function</italic>
</th>
<th align="center" charoff="50" valign="top">
<italic>CADD score v1.3</italic>
</th>
<th align="center" char="." charoff="50" valign="top">
<italic>ExAC allele frequency x10</italic>
<sup>−<italic>6</italic></sup>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" charoff="50" valign="top">PKMR24</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>ZSCAN25 (ZNF498)</italic>
</td>
<td align="left" charoff="50" valign="top">Chr7:99219114A&gt;G</td>
<td align="left" charoff="50" valign="top">NM_145115.2</td>
<td align="left" charoff="50" valign="top">c.506A&gt;G</td>
<td align="left" charoff="50" valign="top">p.(Glu169Gly)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Zinc finger protein nucleic acid binding</td>
<td align="center" charoff="50" valign="top">26.5</td>
<td align="char" char="." charoff="50" valign="top">0</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR33</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>DPH1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr17:1944817C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_001383.3</td>
<td align="left" charoff="50" valign="top">c.1144C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Pro382Ser)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Diphthamide biosynthesis</td>
<td align="center" charoff="50" valign="top">32</td>
<td align="char" char="." charoff="50" valign="top">8.515</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR40</td>
<td align="left" charoff="50" valign="top">Pathan</td>
<td align="left" charoff="50" valign="top">
<italic>DCTN2</italic>
</td>
<td align="left" charoff="50" valign="top">Chr12:57929561T&gt;G</td>
<td align="left" charoff="50" valign="top">NM_001261412.1</td>
<td align="left" charoff="50" valign="top">c.173A&gt;C</td>
<td align="left" charoff="50" valign="top">p.(Lys58Thr)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Structural protein</td>
<td align="center" charoff="50" valign="top">26.8</td>
<td align="char" char="." charoff="50" valign="top">8.484</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR43</td>
<td align="left" charoff="50" valign="top">Pathan</td>
<td align="left" charoff="50" valign="top">
<italic>METTL5</italic>
</td>
<td align="left" charoff="50" valign="top">Chr2:170677663_64delTC</td>
<td align="left" charoff="50" valign="top">NM_014168.3</td>
<td align="left" charoff="50" valign="top">c.344_345delGA</td>
<td align="left" charoff="50" valign="top">p.(Arg115Asnfs*19)</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="left" charoff="50" valign="top">Methyl transferase</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">0</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR45</td>
<td align="left" charoff="50" valign="top">Pathan</td>
<td align="left" charoff="50" valign="top">
<italic>TANGO2 (C22orf25)</italic>
</td>
<td align="left" charoff="50" valign="top">Chr22:20041047G&gt;T</td>
<td align="left" charoff="50" valign="top">NM_152906.5</td>
<td align="left" charoff="50" valign="top">c.353G&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Gly118Val)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Transport and Golgi organization</td>
<td align="center" charoff="50" valign="top">29.4</td>
<td align="char" char="." charoff="50" valign="top">0</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR64</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>CAPN12</italic>
<xref ref-type="fn" rid="t2-fn3">b</xref>
</td>
<td align="left" charoff="50" valign="top">Chr19:39230761_62delTT</td>
<td align="left" charoff="50" valign="top">NM_144691.4</td>
<td align="left" charoff="50" valign="top">c.658_659delAA</td>
<td align="left" charoff="50" valign="top">p.(Asn220Glnfs*25)</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="left" charoff="50" valign="top">Cystine protease</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">795.1</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR66</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>TBC1D8</italic>
</td>
<td align="left" charoff="50" valign="top">Chr2:101652537G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_001102426.1</td>
<td align="left" charoff="50" valign="top">c.1501C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Leu501Phe)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">G-protein modulator</td>
<td align="center" charoff="50" valign="top">31.0</td>
<td align="char" char="." charoff="50" valign="top">99.37</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR67</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>MSS51</italic>
<italic>(ZMYND17)</italic>
</td>
<td align="left" charoff="50" valign="top">Chr10:75187870G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_001024593.1</td>
<td align="left" charoff="50" valign="top">c.173C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Ser58Leu)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Zinc finger transcription factor</td>
<td align="center" charoff="50" valign="top">33.0</td>
<td align="char" char="." charoff="50" valign="top">140.1</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR72</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>MDGA2</italic>
</td>
<td align="left" charoff="50" valign="top">Chr14:47343402T&gt;C</td>
<td align="left" charoff="50" valign="top">NM_001113498.2</td>
<td align="left" charoff="50" valign="top">c.2232A&gt;G</td>
<td align="left" charoff="50" valign="top">p.(Arg744Arg)</td>
<td align="left" charoff="50" valign="top">Aberrant Splicing</td>
<td align="left" charoff="50" valign="top">GPI anchor</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">52.83</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR98</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>FMOD</italic>
</td>
<td align="left" charoff="50" valign="top">Chr1:203316893C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_002023.4</td>
<td align="left" charoff="50" valign="top">c.506G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Arg169Gln)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Receptor</td>
<td align="center" charoff="50" valign="top">23.3</td>
<td align="char" char="." charoff="50" valign="top">296.6</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR118</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>C22orf31</italic>
</td>
<td align="left" charoff="50" valign="top">Chr22:29454885C&gt;G</td>
<td align="left" charoff="50" valign="top">NM_015370.1</td>
<td align="left" charoff="50" valign="top">c.718G&gt;C</td>
<td align="left" charoff="50" valign="top">p.(Gly240Arg)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Unknown</td>
<td align="center" charoff="50" valign="top">28.6</td>
<td align="char" char="." charoff="50" valign="top">0</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR142</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>SMARCA1</italic>
</td>
<td align="left" charoff="50" valign="top">ChrX:128657269C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_139035.2</td>
<td align="left" charoff="50" valign="top">c.79G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Glu27Lys)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Component of NURF complex</td>
<td align="center" charoff="50" valign="top">22.1</td>
<td align="char" char="." charoff="50" valign="top">35.55</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR153</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>GPAA1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr8:145138854G&gt;C</td>
<td align="left" charoff="50" valign="top">NM_003801.3</td>
<td align="left" charoff="50" valign="top">c.527G&gt;C</td>
<td align="left" charoff="50" valign="top">p.(Trp176Ser)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Glycosylphosphatidylinositol</td>
<td align="center" charoff="50" valign="top">27.6</td>
<td align="char" char="." charoff="50" valign="top">16.58</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR155</td>
<td align="left" charoff="50" valign="top">Kashmiri</td>
<td align="left" charoff="50" valign="top">
<italic>OR2A12</italic>
</td>
<td align="left" charoff="50" valign="top">Chr7:143792562G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_001004135.1</td>
<td align="left" charoff="50" valign="top">c.362G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Arg121Gln)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Olfactory receptor</td>
<td align="center" charoff="50" valign="top">24.1</td>
<td align="char" char="." charoff="50" valign="top">16.57</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR159</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>AACS</italic>
</td>
<td align="left" charoff="50" valign="top">Chr12:125612785A&gt;G</td>
<td align="left" charoff="50" valign="top">NM_023928.3</td>
<td align="left" charoff="50" valign="top">c.1388A&gt;G;</td>
<td align="left" charoff="50" valign="top">p.(Asn463Ser);</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Acetoacetyl-Co synthetase</td>
<td align="center" charoff="50" valign="top">21.2</td>
<td align="char" char="." charoff="50" valign="top">82.95</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">Chr12:125621351C&gt;T</td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">c.1822C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Arg608Cys)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top"> </td>
<td align="center" charoff="50" valign="top">34.0</td>
<td align="char" char="." charoff="50" valign="top">198.1</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR164</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>GGN</italic>
</td>
<td align="left" charoff="50" valign="top">Chr19:38877823G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_152657.3</td>
<td align="left" charoff="50" valign="top">c.79C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Arg27Cys)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Germ cell specific gene</td>
<td align="center" charoff="50" valign="top">25.9</td>
<td align="char" char="." charoff="50" valign="top">362.3</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR174</td>
<td align="left" charoff="50" valign="top">Siraki</td>
<td align="left" charoff="50" valign="top">
<italic>MEGF9</italic>
</td>
<td align="left" charoff="50" valign="top">Chr9:123421769C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_001080497.2</td>
<td align="left" charoff="50" valign="top">c.686G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Gly229Asp)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Receptor</td>
<td align="center" charoff="50" valign="top">26.8</td>
<td align="char" char="." charoff="50" valign="top">59.54</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR195</td>
<td align="left" charoff="50" valign="top">Siraki</td>
<td align="left" charoff="50" valign="top">
<italic>WFDC1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr16:84360517G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_021197.3</td>
<td align="left" charoff="50" valign="top">c.634G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Gly212Arg)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Protease inhibitor</td>
<td align="center" charoff="50" valign="top">24.2</td>
<td align="char" char="." charoff="50" valign="top">65.89</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR198</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>METTL4</italic>
</td>
<td align="left" charoff="50" valign="top">Chr18:2554909G&gt;T</td>
<td align="left" charoff="50" valign="top">NM_022840.4</td>
<td align="left" charoff="50" valign="top">c.588C&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Cys196*)</td>
<td align="left" charoff="50" valign="top">Nonsense</td>
<td align="left" charoff="50" valign="top">Methyl transferase</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">41.19</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR200</td>
<td align="left" charoff="50" valign="top">Siraiki</td>
<td align="left" charoff="50" valign="top">
<italic>UBE2J2</italic>
</td>
<td align="left" charoff="50" valign="top">Chr1:1203295_96delTT</td>
<td align="left" charoff="50" valign="top">NM_194315.1</td>
<td align="left" charoff="50" valign="top">c.77_78delAA</td>
<td align="left" charoff="50" valign="top">p.(Lys26Argfs*30)</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="left" charoff="50" valign="top">Ubiquitin protein ligase</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">0</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR206</td>
<td align="left" charoff="50" valign="top">Siraiki</td>
<td align="left" charoff="50" valign="top">
<italic>CCDC82</italic>
</td>
<td align="left" charoff="50" valign="top">Chr11:96117539delC</td>
<td align="left" charoff="50" valign="top">NM_024725.3</td>
<td align="left" charoff="50" valign="top">c.373delG</td>
<td align="left" charoff="50" valign="top">p.(Asp125Ilefs*6)</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="left" charoff="50" valign="top">Unknown</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">0</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR213</td>
<td align="left" charoff="50" valign="top">Siraiki Baloch</td>
<td align="left" charoff="50" valign="top">
<italic>TMEM222</italic>
</td>
<td align="left" charoff="50" valign="top">Chr1:27657230G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_032125.2</td>
<td align="left" charoff="50" valign="top">c.214G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Gly72Ser)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Transmembrane protein</td>
<td align="center" charoff="50" valign="top">34.0</td>
<td align="char" char="." charoff="50" valign="top">8.237</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR215</td>
<td align="left" charoff="50" valign="top">Siraiki</td>
<td align="left" charoff="50" valign="top">
<italic>PUS7</italic>
</td>
<td align="left" charoff="50" valign="top">chr7:105148870_71delTG</td>
<td align="left" charoff="50" valign="top">NM_019042.3</td>
<td align="left" charoff="50" valign="top">c.89_90delCA</td>
<td align="left" charoff="50" valign="top">p.(Thr30Lysfs*20)</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="left" charoff="50" valign="top">Pseudouridylate synthetase</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">8.237</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR258</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>AREL1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr14:75150203G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_001039479.1</td>
<td align="left" charoff="50" valign="top">c.277C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(His93Tyr)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Ubiquitin-protein ligase</td>
<td align="center" charoff="50" valign="top">23.1</td>
<td align="center" char="." charoff="50" valign="top">1102</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR298</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>SEPT6</italic>
</td>
<td align="left" charoff="50" valign="top">ChrX:118797529T&gt;C</td>
<td align="left" charoff="50" valign="top">NM_145799.3</td>
<td align="left" charoff="50" valign="top">c.257A&gt;G</td>
<td align="left" charoff="50" valign="top">p.(Tyr86Cys)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Filament formation</td>
<td align="center" charoff="50" valign="top">26.4</td>
<td align="char" char="." charoff="50" valign="top">11.41</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR318</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>DUOX1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr15:45444197G&gt;T</td>
<td align="left" charoff="50" valign="top">NM_175940.2</td>
<td align="left" charoff="50" valign="top">c.3140G&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Cys1047Phe)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Oxidase</td>
<td align="center" charoff="50" valign="top">22.9</td>
<td align="char" char="." charoff="50" valign="top">16.59</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR320</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>SLC7A10</italic>
</td>
<td align="left" charoff="50" valign="top">Chr19:33700282_83dupA</td>
<td align="left" charoff="50" valign="top">NM_019849.2</td>
<td align="left" charoff="50" valign="top">c.1372_1373dupA</td>
<td align="left" charoff="50" valign="top">p.(Thr458Asnfs*71)</td>
<td align="left" charoff="50" valign="top">Frameshift</td>
<td align="left" charoff="50" valign="top">Transporter</td>
<td align="center" charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">16.49</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR325</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>TM2D3</italic>
</td>
<td align="left" charoff="50" valign="top">Chr15:102182749G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_078474.2</td>
<td align="left" charoff="50" valign="top">c.677C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Thr226Met)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Cell death or proliferation</td>
<td align="center" charoff="50" valign="top">31.0</td>
<td align="char" char="." charoff="50" valign="top">8.344</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR326</td>
<td align="left" charoff="50" valign="top">Pathan</td>
<td align="left" charoff="50" valign="top">
<italic>PRKAR2B</italic>
</td>
<td align="left" charoff="50" valign="top">Chr7:106797706G&gt;T</td>
<td align="left" charoff="50" valign="top">NM_002736.2</td>
<td align="left" charoff="50" valign="top">c.1060G&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Ala354Ser)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Kinase modulator</td>
<td align="center" charoff="50" valign="top">32.0</td>
<td align="char" char="." charoff="50" valign="top">8.247</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR396</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>RGR</italic>
</td>
<td align="left" charoff="50" valign="top">Chr10:86008779G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_002921.3</td>
<td align="left" charoff="50" valign="top">c.350G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Arg117His)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Retinal G-protein coupled receptor</td>
<td align="center" charoff="50" valign="top">26.5</td>
<td align="char" char="." charoff="50" valign="top">107.3</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t2-fn1">
<p>Abbreviations: GPI, Glycophosphatidylinositol; NA, Not
Applicable.</p>
</fn>
<fn id="t2-fn2">
<label>a</label>
<p>Chromosomal position according to GRCh37/hg19.</p>
</fn>
<fn id="t2-fn3">
<label>b</label>
<p>This frameshift allele of <italic>CAPN12</italic> has been documented in
apparently healthy British–Pakistani individual in a
homozygous fashion.<sup><xref ref-type="bibr" rid="bib35">35</xref></sup></p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tbl3a">
<label>Table 3a</label>
<caption>
<title>Multiple known genes segregating in same families</title>
</caption>
<table border="1" frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead valign="bottom">
<tr>
<th align="left" charoff="50" valign="top">
<italic>Family</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Ethnicity</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Genes</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Position</italic>
<xref ref-type="fn" rid="t3a-fn2">a</xref>
</th>
<th align="left" charoff="50" valign="top">
<italic>Transcript</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>cDNA mutation</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Protein change</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Variation</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Protein function</italic>
</th>
<th align="center" char="." charoff="50" valign="top">
<italic>CADD score V1.3</italic>
</th>
<th align="center" char="." charoff="50" valign="top">
<italic>ExAC allele frequency x10</italic>
<sup>−<italic>6</italic></sup>
</th>
<th align="center" char="." charoff="50" valign="top">
<italic>OMIM</italic>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" charoff="50" valign="top">PKMR61b</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>TMEM67</italic>
</td>
<td align="left" charoff="50" valign="top">Chr8:94827616G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_153704.5</td>
<td align="left" charoff="50" valign="top">c.2848G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Val950Met)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Centriole migration to the apical membrane</td>
<td align="char" char="." charoff="50" valign="top">32.0</td>
<td align="char" char="." charoff="50" valign="top">8.516</td>
<td align="char" char="." charoff="50" valign="top">609884</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>FGFR1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr8:38271255G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_023110.2</td>
<td align="left" charoff="50" valign="top">c.2360C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Thr787Met)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Fibroblast growth factor receptor</td>
<td align="char" char="." charoff="50" valign="top">29.2</td>
<td align="char" char="." charoff="50" valign="top">126.8</td>
<td align="char" char="." charoff="50" valign="top">136350</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR69</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>FRAS1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr4:79443907G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_025074.6</td>
<td align="left" charoff="50" valign="top">c.10753G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Ala3585Thr)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Extracellular matrix protein</td>
<td align="char" char="." charoff="50" valign="top">24.4</td>
<td align="char" char="." charoff="50" valign="top">27.21</td>
<td align="char" char="." charoff="50" valign="top">607830</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>EXOSC8</italic>
</td>
<td align="left" charoff="50" valign="top">Chr13:37580059C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_181503.2</td>
<td align="left" charoff="50" valign="top">c.241C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Pro81Ser)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Exosome component</td>
<td align="char" char="." charoff="50" valign="top">28.2</td>
<td align="char" char="." charoff="50" valign="top">173.6</td>
<td align="char" char="." charoff="50" valign="top">606019</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t3a-fn1">
<p>Abbreviations: OMIM, Online Mendelian Inheritance In Man.</p>
</fn>
<fn id="t3a-fn2">
<label>a</label>
<p>Chromosomal position according to GRCh37/hg19.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tbl3b">
<label>Table 3b</label>
<caption>
<title>Multiple novel candidate genes segregating in the same family</title>
</caption>
<table border="1" frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead valign="bottom">
<tr>
<th align="left" charoff="50" valign="top">
<italic>Family</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Ethnicity</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Genes</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Position</italic>
<xref ref-type="fn" rid="t3b-fn2">a</xref>
</th>
<th align="left" charoff="50" valign="top">
<italic>Transcript</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>cDNA mutation</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Protein change</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Variation</italic>
</th>
<th align="left" charoff="50" valign="top">
<italic>Protein function</italic>
</th>
<th align="center" char="." charoff="50" valign="top">
<italic>CADD score V1.3</italic>
</th>
<th align="center" char="." charoff="50" valign="top">
<italic>ExAC allele frequency x10</italic>
<sup>−<italic>6</italic></sup>
</th>
<th align="center" char="." charoff="50" valign="top">
<italic>OMIM</italic>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" charoff="50" valign="top">PKMR30</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>DGCR8</italic>
</td>
<td align="left" charoff="50" valign="top">Chr22:20073866G&gt;A</td>
<td align="left" charoff="50" valign="top">NM_022720.6</td>
<td align="left" charoff="50" valign="top">c.380G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Ser127Asn)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">miRNA biogenesis</td>
<td align="char" char="." charoff="50" valign="top">22.9</td>
<td align="char" char="." charoff="50" valign="top">8.248</td>
<td align="char" char="." charoff="50" valign="top">609030</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>FNIP2</italic>
</td>
<td align="left" charoff="50" valign="top">Chr4:159812659G&gt;T</td>
<td align="left" charoff="50" valign="top">NM_020840.1</td>
<td align="left" charoff="50" valign="top">c.3011G&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Trp1004Leu)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Folliculin-interacting protein</td>
<td align="char" char="." charoff="50" valign="top">23.6</td>
<td align="char" char="." charoff="50" valign="top">967.4</td>
<td align="char" char="." charoff="50" valign="top">612768</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>GSTCD</italic>
</td>
<td align="left" charoff="50" valign="top">Chr4:106640368A&gt;G</td>
<td align="left" charoff="50" valign="top">NM_001031720.3</td>
<td align="left" charoff="50" valign="top">c.578A&gt;G</td>
<td align="left" charoff="50" valign="top">p.(Asp193Gly)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Glutathione <italic>S</italic>-transferase</td>
<td align="char" char="." charoff="50" valign="top">29.8</td>
<td align="char" char="." charoff="50" valign="top">49.49</td>
<td align="char" char="." charoff="50" valign="top">615912</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>TOP3B</italic>
</td>
<td align="left" charoff="50" valign="top">Chr22:22318366G&gt;T</td>
<td align="left" charoff="50" valign="top">NM_003935.4</td>
<td align="left" charoff="50" valign="top">c.1133C&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Pro378Gln)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Topoisomerase</td>
<td align="char" char="." charoff="50" valign="top">27.6</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">603582</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR51b</td>
<td align="left" charoff="50" valign="top">Pathan</td>
<td align="left" charoff="50" valign="top">
<italic>CPT1B</italic>
</td>
<td align="left" charoff="50" valign="top">Chr22:51008816C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_152245.2</td>
<td align="left" charoff="50" valign="top">c.2048G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Arg683His)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Acetyltransferase</td>
<td align="char" char="." charoff="50" valign="top">35.0</td>
<td align="char" char="." charoff="50" valign="top">164.2</td>
<td align="char" char="." charoff="50" valign="top">601987</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>PHACTR1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr6:13228209C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_030948.2</td>
<td align="left" charoff="50" valign="top">c.1148C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Ser383Leu)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Phosphatase and actin regulator</td>
<td align="char" char="." charoff="50" valign="top">23.2</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">608723</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR52</td>
<td align="left" charoff="50" valign="top">Pathan</td>
<td align="left" charoff="50" valign="top">
<italic>STX19</italic>
</td>
<td align="left" charoff="50" valign="top">Chr3:93733695A&gt;G</td>
<td align="left" charoff="50" valign="top">NM_001001850.2</td>
<td align="left" charoff="50" valign="top">c.419T&gt;C</td>
<td align="left" charoff="50" valign="top">p.(Met140Thr)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">SNARE protein</td>
<td align="char" char="." charoff="50" valign="top">24.1</td>
<td align="char" char="." charoff="50" valign="top">82.42</td>
<td align="center" char="." charoff="50" valign="top">—</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>TBC1D23</italic>
</td>
<td align="left" charoff="50" valign="top">Chr3:100035033T&gt;G</td>
<td align="left" charoff="50" valign="top">NM_001199198.2</td>
<td align="left" charoff="50" valign="top">c.1687+2T&gt;G</td>
<td align="left" charoff="50" valign="top">p.(Asp563Glyfs*33)</td>
<td align="left" charoff="50" valign="top">Aberrant splicing</td>
<td align="left" charoff="50" valign="top">Rab GTPase activator</td>
<td align="center" char="." charoff="50" valign="top">NA</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="center" char="." charoff="50" valign="top">—</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR65</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>DNAJC2</italic>
</td>
<td align="left" charoff="50" valign="top">Chr7:102956464A&gt;G</td>
<td align="left" charoff="50" valign="top">NM_014377.1</td>
<td align="left" charoff="50" valign="top">c.1499T&gt;C</td>
<td align="left" charoff="50" valign="top">p.(Ile500Thr)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Phosphoprotein</td>
<td align="char" char="." charoff="50" valign="top">29.7</td>
<td align="char" char="." charoff="50" valign="top">75.31</td>
<td align="char" char="." charoff="50" valign="top">605502</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>LINGO1</italic>
</td>
<td align="left" charoff="50" valign="top">Chr15:77907386T&gt;C</td>
<td align="left" charoff="50" valign="top">NM_032808.6</td>
<td align="left" charoff="50" valign="top">c.863A&gt;G</td>
<td align="left" charoff="50" valign="top">p.(Tyr288Cys)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Cell signaling</td>
<td align="char" char="." charoff="50" valign="top">24.6</td>
<td align="char" char="." charoff="50" valign="top">8.285</td>
<td align="char" char="." charoff="50" valign="top">609791</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>VAPA</italic>
</td>
<td align="left" charoff="50" valign="top">Chr18:9945020A&gt;G</td>
<td align="left" charoff="50" valign="top">NM_003574.5</td>
<td align="left" charoff="50" valign="top">c.517A&gt;G</td>
<td align="left" charoff="50" valign="top">p.(Arg173Gly)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Membrane protein</td>
<td align="char" char="." charoff="50" valign="top">21.6</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">605703</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR120</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>LRRC6</italic>
</td>
<td align="left" charoff="50" valign="top">Chr8:133669098A&gt;C</td>
<td align="left" charoff="50" valign="top">NM_012472.4</td>
<td align="left" charoff="50" valign="top">c.234T&gt;G</td>
<td align="left" charoff="50" valign="top">p.(Ile78Met)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Receptor extracellular matrix protein</td>
<td align="char" char="." charoff="50" valign="top">24.7</td>
<td align="char" char="." charoff="50" valign="top">185.7</td>
<td align="char" char="." charoff="50" valign="top">614930</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>SLC45A4</italic>
</td>
<td align="left" charoff="50" valign="top">Chr8:142228631C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_001080431.2</td>
<td align="left" charoff="50" valign="top">c.955G&gt;A</td>
<td align="left" charoff="50" valign="top">p.(Asp319Asn)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Solute carrier</td>
<td align="char" char="." charoff="50" valign="top">24.8</td>
<td align="char" char="." charoff="50" valign="top">375.2</td>
<td align="center" char="." charoff="50" valign="top">—</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top">PKMR131</td>
<td align="left" charoff="50" valign="top">Punjabi</td>
<td align="left" charoff="50" valign="top">
<italic>ESYT3</italic>
</td>
<td align="left" charoff="50" valign="top">Chr3:138191644C&gt;T</td>
<td align="left" charoff="50" valign="top">NM_031913.3</td>
<td align="left" charoff="50" valign="top">c.2180C&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Ser727Leu)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Extended synaptotagmin</td>
<td align="char" char="." charoff="50" valign="top">34</td>
<td align="char" char="." charoff="50" valign="top">124.3</td>
<td align="char" char="." charoff="50" valign="top">616692</td>
</tr>
<tr>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top"> </td>
<td align="left" charoff="50" valign="top">
<italic>CCT6B</italic>
</td>
<td align="left" charoff="50" valign="top">Chr17:33285649C&gt;A</td>
<td align="left" charoff="50" valign="top">NM_001193529.2</td>
<td align="left" charoff="50" valign="top">c.266G&gt;T</td>
<td align="left" charoff="50" valign="top">p.(Gly89Val)</td>
<td align="left" charoff="50" valign="top">Missense</td>
<td align="left" charoff="50" valign="top">Chaperonin-containing T-complex</td>
<td align="char" char="." charoff="50" valign="top">31</td>
<td align="char" char="." charoff="50" valign="top">0</td>
<td align="char" char="." charoff="50" valign="top">610730</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t3b-fn1">
<p>Abbreviations: NA, Not Applicable; OMIM, Online Mendelian Inheritance
In Man.</p>
</fn>
<fn id="t3b-fn2">
<label>a</label>
<p>Chromosomal position according to GRCh37/hg19.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>